query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_1503_ESMFold_hypothetical_protein	3w0m-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3w0m-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia, apo form	0.184	311	235	14	324	1	289	7.307E-13	379
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	0.142	316	245	10	325	2	288	6.541E-12	330
LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	0.148	316	248	10	325	2	293	8.545E-12	330
LOKIASV2_1503_ESMFold_hypothetical_protein	4n57-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4n57-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-IVa ADP complex	0.157	308	248	12	319	2	296	1.458E-11	329
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.139	308	248	10	317	2	290	1.116E-11	325
LOKIASV2_1503_ESMFold_hypothetical_protein	6c5u-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6c5u-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Ribostamycin, Alternate form	0.138	317	247	9	325	3	289	1.178E-11	319
LOKIASV2_1503_ESMFold_hypothetical_protein	6cgd-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6cgd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Amikacin	0.151	317	245	9	325	5	293	1.242E-11	319
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqf-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqf-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of APH(6')-Ie/APH(2'')-Ia) in complex with GDP and Magnesium	0.137	309	246	9	317	5	290	2.010E-11	317
LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	0.145	309	244	9	317	5	290	2.770E-11	316
LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly4.cif.gz_D Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	0.141	316	248	10	325	2	291	3.619E-11	315
LOKIASV2_1503_ESMFold_hypothetical_protein	4dfb-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4dfb-assembly2.cif.gz_B Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	0.153	311	252	12	322	3	300	3.817E-11	315
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	0.157	317	244	9	325	2	291	1.806E-11	314
LOKIASV2_1503_ESMFold_hypothetical_protein	3n4v-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3n4v-assembly2.cif.gz_B apo APH(2")-IVa form III	0.155	309	249	12	320	3	298	3.619E-11	313
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.158	309	239	9	317	9	293	3.817E-11	313
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqd-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Ribostamycin	0.147	309	245	9	317	5	292	1.905E-11	313
LOKIASV2_1503_ESMFold_hypothetical_protein	6cey-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6cey-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Lividomycin moieties	0.149	308	235	18	325	9	285	2.922E-11	309
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqe-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqe-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	0.159	316	241	10	325	2	288	2.120E-11	307
LOKIASV2_1503_ESMFold_hypothetical_protein	3tdw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3tdw-assembly1.cif.gz_A The GDP complex of the aminoglycoside 2'-phosphotransfere-IIIa F108L mutant	0.138	316	252	9	324	3	295	8.069E-11	306
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	0.153	316	243	10	325	2	289	4.027E-11	305
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqb-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqb-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Kanamycin A	0.154	311	239	15	325	6	289	3.082E-11	305
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	0.151	316	247	10	325	2	293	6.873E-11	304
LOKIASV2_1503_ESMFold_hypothetical_protein	6ctz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6ctz-assembly1.cif.gz_A Structure of the GDP and kanamycin complex of APH(2")-IIia	0.123	307	251	18	324	8	294	3.070E-10	302
LOKIASV2_1503_ESMFold_hypothetical_protein	4dta-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4dta-assembly1.cif.gz_A Crystal Structure of F95M Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Adenosine	0.153	313	249	12	324	3	297	4.987E-11	302
LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	0.142	316	247	10	325	2	290	7.250E-11	300
LOKIASV2_1503_ESMFold_hypothetical_protein	4dfb-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4dfb-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	0.159	308	246	12	319	3	295	5.261E-11	300
LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	0.147	314	241	12	325	1	283	9.472E-11	298
LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly3.cif.gz_C Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	0.160	306	241	10	315	2	289	6.900E-12	296
LOKIASV2_1503_ESMFold_hypothetical_protein	6cgg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6cgg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	0.135	317	251	9	325	2	292	9.472E-11	296
LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4ork-assembly2.cif.gz_B Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	0.139	309	246	9	317	4	290	1.705E-10	296
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqc-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.149	307	240	9	315	5	287	2.112E-10	295
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	0.148	317	244	9	325	5	291	8.512E-11	295
LOKIASV2_1503_ESMFold_hypothetical_protein	4dtb-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4dtb-assembly2.cif.gz_B Crystal Structure of F95Y Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Guanosine	0.147	308	251	12	319	3	297	1.305E-10	292
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqe-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqe-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	0.152	317	241	9	325	5	289	1.705E-10	290
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqg-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqg-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	0.161	317	237	9	325	4	287	2.479E-10	286
LOKIASV2_1503_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	0.157	312	244	15	326	9	298	5.528E-10	286
LOKIASV2_1503_ESMFold_hypothetical_protein	3tdv-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3tdv-assembly2.cif.gz_B Structure of the GDP complex of wild-type aminoglycoside 2'-phosphotransferase-IIIa	0.139	312	253	15	326	5	299	7.619E-10	281
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqh-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	0.144	308	235	18	325	11	285	3.605E-10	278
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqi-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	0.146	317	242	9	325	5	288	5.241E-10	277
LOKIASV2_1503_ESMFold_hypothetical_protein	6cgg-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6cgg-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	0.152	301	225	26	326	24	289	2.911E-10	275
LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6cav-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	0.151	317	239	10	326	2	284	5.528E-10	271
LOKIASV2_1503_ESMFold_hypothetical_protein	5iqb-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5iqb-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Kanamycin A	0.160	318	239	9	326	4	289	9.435E-10	270
LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.150	301	237	15	315	9	288	2.104E-09	265
LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6ch4-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	0.138	317	241	10	326	2	282	6.490E-10	263
LOKIASV2_1503_ESMFold_hypothetical_protein	7w1a-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7w1a-assembly1.cif.gz_B Crystal Structure of MPH-E in complex with GMP and Azithromycin	0.139	295	238	15	309	6	283	1.610E-09	259
LOKIASV2_1503_ESMFold_hypothetical_protein	4fex-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4fex-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	0.104	266	215	26	291	18	258	3.996E-09	256
LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly6.cif.gz_F	LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.117	265	210	27	291	6	244	5.507E-09	248
LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly3.cif.gz_C Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.162	296	229	15	310	9	282	1.228E-08	247
LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly1.cif.gz_A Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.102	280	228	12	291	8	262	3.788E-09	246
LOKIASV2_1503_ESMFold_hypothetical_protein	1l8t-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1l8t-assembly1.cif.gz_A Crystal Structure Of 3',5"-Aminoglycoside Phosphotransferase Type IIIa ADP Kanamycin A Complex	0.147	280	217	12	291	6	260	1.295E-08	244
LOKIASV2_1503_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	0.144	306	255	14	319	1	299	3.047E-08	243
LOKIASV2_1503_ESMFold_hypothetical_protein	4fex-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4fex-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	0.108	265	215	27	291	19	260	8.006E-09	242
LOKIASV2_1503_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II - complex with GDP and clarithromycin	0.131	302	248	17	318	9	294	2.096E-08	242
LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly9.cif.gz_F	LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.103	265	215	27	291	11	251	1.441E-08	241
LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.106	280	224	12	291	16	267	8.446E-09	240
LOKIASV2_1503_ESMFold_hypothetical_protein	5igh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5igh-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type I	0.125	294	239	27	320	27	300	6.465E-09	240
LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly17.cif.gz_I	LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly17.cif.gz_I Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.113	265	215	27	291	23	265	7.194E-09	239
LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly18.cif.gz_K	LOKIASV2_1503_ESMFold_hypothetical_protein	4gkh-assembly18.cif.gz_K Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.101	280	227	12	291	15	268	9.399E-09	239
LOKIASV2_1503_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	0.159	300	236	15	314	6	287	1.233E-09	239
LOKIASV2_1503_ESMFold_hypothetical_protein	4few-assembly8.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	4few-assembly8.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.111	265	217	27	291	21	265	1.295E-08	237
LOKIASV2_1503_ESMFold_hypothetical_protein	4h05-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4h05-assembly1.cif.gz_A Crystal structure of aminoglycoside-3'-phosphotransferase of type VIII	0.166	275	218	17	291	6	267	1.366E-08	237
LOKIASV2_1503_ESMFold_hypothetical_protein	4gki-assembly6.cif.gz_F	LOKIASV2_1503_ESMFold_hypothetical_protein	4gki-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NM-PP1	0.111	265	213	27	291	20	260	1.366E-08	235
LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly7.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4fev-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.110	265	214	27	291	13	253	2.738E-08	232
LOKIASV2_1503_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	0.161	280	213	12	291	5	259	1.785E-08	232
LOKIASV2_1503_ESMFold_hypothetical_protein	4ej7-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4ej7-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound	0.092	280	230	12	291	11	264	4.199E-08	229
LOKIASV2_1503_ESMFold_hypothetical_protein	3jr1-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3jr1-assembly2.cif.gz_B Crystal structure of Putative fructosamine-3-kinase (YP_719053.1) from HAEMOPHILUS SOMNUS 129PT at 2.32 A resolution	0.159	302	235	18	319	15	295	6.820E-09	229
LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.110	265	215	27	291	20	262	4.199E-08	226
LOKIASV2_1503_ESMFold_hypothetical_protein	7w1a-assembly2.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7w1a-assembly2.cif.gz_A Crystal Structure of MPH-E in complex with GMP and Azithromycin	0.138	284	228	25	308	19	284	5.485E-08	225
LOKIASV2_1503_ESMFold_hypothetical_protein	4few-assembly7.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4few-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.102	265	216	27	291	15	255	7.975E-08	220
LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.158	298	241	15	312	9	295	4.929E-08	218
LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4feu-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.105	261	210	31	291	26	261	2.096E-08	213
LOKIASV2_1503_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	0.162	280	199	12	291	6	244	1.042E-07	212
LOKIASV2_1503_ESMFold_hypothetical_protein	7w19-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7w19-assembly2.cif.gz_B Crystal Structure of Acinetobacter baumannii MPH-E	0.137	304	249	14	317	1	290	7.560E-08	212
LOKIASV2_1503_ESMFold_hypothetical_protein	2qg7-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2qg7-assembly1.cif.gz_A Plasmodium vivax ethanolamine kinase Pv091845	0.147	319	265	15	326	50	368	3.214E-08	210
LOKIASV2_1503_ESMFold_hypothetical_protein	5igu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5igu-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II	0.141	294	224	26	319	3	264	1.876E-07	209
LOKIASV2_1503_ESMFold_hypothetical_protein	6fux-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6fux-assembly1.cif.gz_A Structure of aminoglycoside phosphotransferase APH(3'')-Id from Streptomyces rimosus ATCC10970 in complex with ADP and streptomycin	0.152	277	217	18	294	9	265	1.598E-07	209
LOKIASV2_1503_ESMFold_hypothetical_protein	6iy9-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6iy9-assembly2.cif.gz_B Crystal structure of aminoglycoside 7"-phoshotransferase-Ia (APH(7")-Ia/HYG) from Streptomyces hygroscopicus complexed with hygromycin B	0.140	298	250	16	313	30	321	1.515E-07	208
LOKIASV2_1503_ESMFold_hypothetical_protein	6fuc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6fuc-assembly1.cif.gz_A Structure of aminoglycoside phosphotransferase APH(3'')-Id from Streptomyces rimosus ATCC10970	0.142	280	221	15	294	11	268	4.199E-08	200
LOKIASV2_1503_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	0.120	298	255	36	326	41	338	8.413E-08	195
LOKIASV2_1503_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B Crystal structure of Mnk1 catalytic domain	0.142	286	191	26	311	10	233	2.844E-04	109
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	0.112	285	215	26	310	12	254	1.086E-04	107
LOKIASV2_1503_ESMFold_hypothetical_protein	6v6a-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6v6a-assembly2.cif.gz_C Inhibitory scaffolding of the ancient MAPK, ERK7	0.108	307	255	16	322	3	289	4.619E-05	106
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly2.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly2.cif.gz_D ASK1 kinase domain in complex with GS-4997	0.093	287	213	26	312	17	252	2.296E-04	105
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	0.111	281	196	25	305	11	231	1.497E-04	104
LOKIASV2_1503_ESMFold_hypothetical_protein	5h2u-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5h2u-assembly4.cif.gz_D Crystal structure of PTK6 Kinase Domain complexed with Dasatinib	0.100	299	227	28	326	11	263	4.853E-04	102
LOKIASV2_1503_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	0.120	299	222	28	326	14	266	1.497E-04	102
LOKIASV2_1503_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	0.103	300	243	26	325	12	283	1.497E-04	102
LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly2.cif.gz_B Crystal structure of ULK2 in complexed with MRT67307	0.126	284	218	28	311	14	263	2.422E-04	100
LOKIASV2_1503_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.116	286	202	26	311	10	238	4.134E-04	100
LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly5.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly5.cif.gz_E PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.145	301	191	24	324	3	226	1.854E-04	100
LOKIASV2_1503_ESMFold_hypothetical_protein	3q4t-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3q4t-assembly1.cif.gz_A Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with dorsomorphin	0.098	293	263	27	319	13	305	2.696E-04	100
LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly1.cif.gz_A Crystal structure of ULK2 in complexed with MRT67307	0.120	283	227	29	311	15	273	1.666E-04	98
LOKIASV2_1503_ESMFold_hypothetical_protein	3h0z-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3h0z-assembly1.cif.gz_A Aurora A in complex with a bisanilinopyrimidine	0.095	288	216	26	313	7	246	1.142E-03	97
LOKIASV2_1503_ESMFold_hypothetical_protein	3h9o-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3h9o-assembly1.cif.gz_A Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9	0.136	301	194	24	324	4	228	2.696E-04	97
LOKIASV2_1503_ESMFold_hypothetical_protein	1zrz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1zrz-assembly1.cif.gz_A Crystal Structure of the Catalytic Domain of Atypical Protein Kinase C-iota	0.116	284	226	28	311	10	266	1.419E-04	97
LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly3.cif.gz_C The structure of human CamKII with bound inhibitor	0.120	301	249	26	326	1	284	2.177E-04	96
LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	0.117	301	252	26	326	5	290	1.146E-04	96
LOKIASV2_1503_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.109	298	225	28	325	11	264	4.150E-05	96
LOKIASV2_1503_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.118	290	229	28	317	11	271	1.086E-04	96
LOKIASV2_1503_ESMFold_hypothetical_protein	5uox-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5uox-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.102	286	215	25	310	12	251	5.401E-04	95
LOKIASV2_1503_ESMFold_hypothetical_protein	3ggf-assembly3.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ggf-assembly3.cif.gz_A Crystal structure of human Serine/threonine-protein kinase MST4 in complex with an quinazolin	0.111	299	226	27	325	11	265	2.063E-04	95
LOKIASV2_1503_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor	0.138	297	209	15	311	3	246	2.422E-04	95
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly6.cif.gz_F	LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly6.cif.gz_F GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.124	284	210	27	310	10	250	6.689E-04	94
LOKIASV2_1503_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.114	297	214	28	324	15	257	6.689E-04	94
LOKIASV2_1503_ESMFold_hypothetical_protein	3ma6-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3ma6-assembly2.cif.gz_B Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	0.119	286	225	28	313	10	265	1.209E-04	94
LOKIASV2_1503_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	0.115	300	210	27	326	24	261	2.844E-04	94
LOKIASV2_1503_ESMFold_hypothetical_protein	7p1l-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7p1l-assembly1.cif.gz_A The MARK3 Kinase Domain Bound To AA-CS-1-008	0.109	290	216	26	315	6	248	2.844E-04	94
LOKIASV2_1503_ESMFold_hypothetical_protein	5w9e-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5w9e-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-186	0.119	298	238	28	325	12	282	9.254E-05	94
LOKIASV2_1503_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.098	285	213	26	310	12	248	3.715E-04	93
LOKIASV2_1503_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.097	286	220	26	311	13	257	5.120E-04	93
LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly2.cif.gz_C Crystal structure of ULK2 in complex with SBI-0206965	0.133	282	209	29	310	17	258	4.134E-04	93
LOKIASV2_1503_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A Crystal Structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine	0.117	287	190	28	314	17	232	4.134E-04	93
LOKIASV2_1503_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	0.115	288	205	26	313	19	251	5.401E-04	92
LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly3.cif.gz_C Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.139	305	228	21	325	3	268	5.120E-04	92
LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly1.cif.gz_A Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.151	305	227	21	325	3	270	4.601E-04	92
LOKIASV2_1503_ESMFold_hypothetical_protein	4jdk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4jdk-assembly1.cif.gz_A Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S peptide substrate	0.107	293	234	26	318	24	286	8.283E-04	92
LOKIASV2_1503_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	0.108	286	223	26	311	25	275	9.724E-04	92
LOKIASV2_1503_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B The MARK3 Kinase Domain Bound To AA-CS-1-008	0.106	292	215	27	318	10	250	1.579E-04	92
LOKIASV2_1503_ESMFold_hypothetical_protein	4uv0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4uv0-assembly1.cif.gz_A Structure of a semisynthetic phosphorylated DAPK	0.110	300	241	26	325	12	283	6.689E-04	92
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly2.cif.gz_B ASK1 kinase domain in complex with GS-4997	0.097	263	186	25	287	12	218	7.056E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	6n3o-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6n3o-assembly1.cif.gz_A Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents	0.128	293	212	27	319	7	250	1.204E-03	91
LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly1.cif.gz_A Crystal structure of ULK2 in complex with SBI-0206965	0.132	282	209	29	310	15	256	5.697E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	2clq-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	2clq-assembly1.cif.gz_A-2 Structure of mitogen-activated protein kinase kinase kinase 5	0.108	210	125	26	235	13	153	4.583E-03	91
LOKIASV2_1503_ESMFold_hypothetical_protein	7mu7-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7mu7-assembly1.cif.gz_A Ask1 bound to compound 3	0.106	285	223	26	310	12	261	7.056E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	1v0p-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1v0p-assembly1.cif.gz_A Structure of P. falciparum PfPK5-Purvalanol B ligand complex	0.120	210	123	26	235	6	146	1.414E-03	91
LOKIASV2_1503_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29	0.137	315	211	9	323	3	247	4.134E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	0.108	286	219	28	313	8	254	5.120E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	5vlo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5vlo-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	0.107	300	253	27	326	7	290	1.419E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	3hmm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3hmm-assembly1.cif.gz_A Structure of Alk5 + GW855857	0.108	291	252	28	318	9	291	7.443E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	4f9b-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4f9b-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and PHA767491	0.093	293	257	15	298	6	298	1.026E-03	91
LOKIASV2_1503_ESMFold_hypothetical_protein	4azs-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4azs-assembly1.cif.gz_A High resolution (2.2 A) crystal structure of WbdD.	0.126	262	192	28	289	221	441	6.010E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	4yjn-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4yjn-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor UW1639	0.111	298	240	28	325	13	283	1.030E-04	91
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.127	284	210	27	310	10	251	1.082E-03	90
LOKIASV2_1503_ESMFold_hypothetical_protein	3ggf-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3ggf-assembly3.cif.gz_B Crystal structure of human Serine/threonine-protein kinase MST4 in complex with an quinazolin	0.113	299	224	27	325	10	263	3.715E-04	90
LOKIASV2_1503_ESMFold_hypothetical_protein	7jij-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7jij-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.110	285	223	27	311	8	259	2.844E-04	90
LOKIASV2_1503_ESMFold_hypothetical_protein	5v19-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5v19-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.102	285	213	26	310	12	249	5.401E-04	89
LOKIASV2_1503_ESMFold_hypothetical_protein	2in6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2in6-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD311839	0.139	298	219	12	309	1	255	2.177E-04	89
LOKIASV2_1503_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A Aurora-A Inhibitor Structure (2nd crystal form)	0.104	286	218	28	313	10	253	5.401E-04	89
LOKIASV2_1503_ESMFold_hypothetical_protein	2clq-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2clq-assembly2.cif.gz_B Structure of mitogen-activated protein kinase kinase kinase 5	0.103	286	220	25	310	12	257	1.660E-03	89
LOKIASV2_1503_ESMFold_hypothetical_protein	6qat-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qat-assembly1.cif.gz_A Crystal structure of ULK2 in complexed with hesperadin	0.125	284	214	28	311	13	257	1.573E-03	89
LOKIASV2_1503_ESMFold_hypothetical_protein	4bic-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4bic-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.099	299	209	28	326	15	247	1.082E-03	89
LOKIASV2_1503_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2 Crystal structure of kinase domain of PknA from Mtb	0.114	297	225	28	324	15	269	1.204E-03	89
LOKIASV2_1503_ESMFold_hypothetical_protein	3qc4-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3qc4-assembly2.cif.gz_B PDK1 in complex with DFG-OUT inhibitor xxx	0.115	311	242	9	319	3	276	2.844E-04	89
LOKIASV2_1503_ESMFold_hypothetical_protein	8ho6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8ho6-assembly1.cif.gz_A ScRIPK WT	0.108	301	239	17	317	8	276	3.325E-03	89
LOKIASV2_1503_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	0.110	286	228	26	311	10	266	3.715E-04	89
LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6bab-assembly2.cif.gz_B The structure of human CamKII with bound inhibitor	0.108	287	229	26	312	1	258	1.340E-03	89
LOKIASV2_1503_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE	0.094	298	247	29	326	10	283	6.689E-04	89
LOKIASV2_1503_ESMFold_hypothetical_protein	4d2t-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4d2t-assembly3.cif.gz_B Structure of MELK in complex with inhibitors	0.141	304	220	12	315	2	258	3.164E-04	89
LOKIASV2_1503_ESMFold_hypothetical_protein	5up3-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5up3-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.095	286	209	25	310	11	242	7.852E-04	88
LOKIASV2_1503_ESMFold_hypothetical_protein	2wmv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2wmv-assembly1.cif.gz_A Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors	0.106	285	218	26	310	2	246	1.340E-03	88
LOKIASV2_1503_ESMFold_hypothetical_protein	5m53-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5m53-assembly1.cif.gz_A Nek2 bound to arylaminopurine inhibitor 11	0.113	285	224	26	310	1	253	1.414E-03	88
LOKIASV2_1503_ESMFold_hypothetical_protein	2j90-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2j90-assembly1.cif.gz_B Crystal structure of human ZIP kinase in complex with a tetracyclic pyridone inhibitor (Pyridone 6)	0.098	284	229	28	311	6	260	2.287E-03	88
LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly4.cif.gz_D Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.135	301	197	26	326	8	236	4.361E-04	88
LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.116	299	226	28	326	7	263	7.056E-04	88
LOKIASV2_1503_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.125	303	209	24	326	6	245	7.852E-04	88
LOKIASV2_1503_ESMFold_hypothetical_protein	5dey-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5dey-assembly2.cif.gz_B Crystal structure of PAK1 in complex with an inhibitor compound G-5555	0.139	318	212	9	326	3	249	6.689E-04	88
LOKIASV2_1503_ESMFold_hypothetical_protein	6ruu-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6ruu-assembly1.cif.gz_B Pseudokinase domain of human IRAK3	0.110	306	252	12	317	1	284	1.956E-04	88
LOKIASV2_1503_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A Crystal structure of a wildtype Polo-like kinase 1 (Plk1) catalytic domain.	0.127	285	219	27	311	19	270	8.738E-04	88
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7i-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7i-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010928a	0.100	276	192	26	301	3	216	7.443E-04	88
LOKIASV2_1503_ESMFold_hypothetical_protein	4ax8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4ax8-assembly1.cif.gz_A Medium resolution structure of the bifunctional kinase- methyltransferase WbdD	0.127	255	185	35	289	237	449	1.142E-03	88
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_A ASK1 kinase domain in complex with GS-4997	0.100	285	184	26	310	17	221	2.833E-03	87
LOKIASV2_1503_ESMFold_hypothetical_protein	6qav-assembly2.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6qav-assembly2.cif.gz_D Crystal structure of ULK2 in complexed with MRT68921	0.132	298	198	29	326	14	242	4.601E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	0.097	296	221	27	322	9	254	1.026E-03	87
LOKIASV2_1503_ESMFold_hypothetical_protein	4bie-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4bie-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.098	286	218	26	311	13	255	6.340E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_C ASK1 kinase domain in complex with Compound 11	0.100	285	222	26	310	12	259	8.283E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6yid-assembly1.cif.gz_B Crystal structure of ULK2 in complex with SBI-0206965	0.132	283	213	29	311	18	263	1.026E-03	87
LOKIASV2_1503_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	0.120	287	228	26	312	9	268	9.724E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	0.113	289	221	27	315	23	272	1.660E-03	87
LOKIASV2_1503_ESMFold_hypothetical_protein	3qd0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3qd0-assembly1.cif.gz_A Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-N-phenyl-3-piperidinecarboxamide	0.138	299	188	26	324	9	227	1.026E-03	87
LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.106	291	231	27	317	16	274	1.142E-03	87
LOKIASV2_1503_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	0.109	286	229	26	311	9	266	5.401E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	7xdw-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7xdw-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	0.092	306	252	14	319	4	281	2.685E-03	87
LOKIASV2_1503_ESMFold_hypothetical_protein	1v0b-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1v0b-assembly1.cif.gz_A Crystal structure of the t198a mutant of pfpk5	0.108	285	248	27	311	7	285	5.401E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	6tsz-assembly1.cif.gz_U	LOKIASV2_1503_ESMFold_hypothetical_protein	6tsz-assembly1.cif.gz_U The ULK4 Pseudokinase Domain Bound To ATPgammaS	0.105	300	234	27	326	10	271	9.218E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	6unq-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6unq-assembly1.cif.gz_A Kinase domain of ALK2-K493A with AMPPNP	0.113	275	184	27	301	6	214	1.026E-03	87
LOKIASV2_1503_ESMFold_hypothetical_protein	4nw6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4nw6-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27	0.134	300	236	27	326	18	290	3.522E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	4f9c-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4f9c-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and XL413	0.102	301	266	15	311	4	304	8.283E-04	87
LOKIASV2_1503_ESMFold_hypothetical_protein	5t6a-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5t6a-assembly1.cif.gz_A Crystal Structure of TgCDPK1 from toxoplasma gondii complexed with 5GA	0.127	298	233	28	325	11	278	3.535E-05	87
LOKIASV2_1503_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.133	283	209	28	310	12	253	1.204E-03	86
LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.108	291	220	27	317	17	264	1.142E-03	86
LOKIASV2_1503_ESMFold_hypothetical_protein	6qg4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qg4-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1h	0.125	299	215	26	324	17	263	1.497E-04	86
LOKIASV2_1503_ESMFold_hypothetical_protein	8a5j-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8a5j-assembly1.cif.gz_A Crystal structure of Human STE20-like kinase 1, MST1 in complex with compound XMU-MP-1	0.097	299	246	27	325	3	275	1.142E-03	86
LOKIASV2_1503_ESMFold_hypothetical_protein	3sc1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3sc1-assembly1.cif.gz_A Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discovery	0.135	301	195	24	324	6	231	1.026E-03	86
LOKIASV2_1503_ESMFold_hypothetical_protein	6b16-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6b16-assembly2.cif.gz_B P21-activated kinase 1 in complex with a 4-azaindole inhibitor	0.138	318	212	9	326	3	249	9.218E-04	86
LOKIASV2_1503_ESMFold_hypothetical_protein	5o1s-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5o1s-assembly1.cif.gz_A Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases	0.113	289	225	25	313	6	260	1.082E-03	86
LOKIASV2_1503_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.104	300	254	26	325	8	292	7.443E-04	86
LOKIASV2_1503_ESMFold_hypothetical_protein	5qin-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5qin-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2-YL}ACETAMIDE	0.097	298	247	29	326	10	283	7.056E-04	86
LOKIASV2_1503_ESMFold_hypothetical_protein	3g2f-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3g2f-assembly1.cif.gz_A Crystal structure of the kinase domain of bone morphogenetic protein receptor type II (BMPR2) at 2.35 A resolution	0.116	291	253	27	317	10	296	1.948E-03	86
LOKIASV2_1503_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 3 monomers in the asymmetric unit	0.101	300	256	26	325	13	298	1.204E-03	86
LOKIASV2_1503_ESMFold_hypothetical_protein	4y5q-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4y5q-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with AMP	0.112	288	226	26	313	12	267	3.000E-04	86
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.121	284	212	27	310	11	252	2.055E-03	85
LOKIASV2_1503_ESMFold_hypothetical_protein	6vre-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6vre-assembly2.cif.gz_B Structure of ASK1 bound to BIO-1772961	0.102	285	219	26	310	14	258	2.168E-03	85
LOKIASV2_1503_ESMFold_hypothetical_protein	5d7v-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5d7v-assembly4.cif.gz_D Crystal structure of PTK6 kinase domain	0.114	299	224	28	326	11	264	2.685E-03	85
LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.113	287	228	26	312	8	265	2.988E-03	85
LOKIASV2_1503_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	0.132	301	194	24	324	7	231	9.724E-04	85
LOKIASV2_1503_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	0.098	301	212	26	326	27	262	8.738E-04	85
LOKIASV2_1503_ESMFold_hypothetical_protein	7up8-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7up8-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.098	296	232	29	324	17	274	1.270E-03	85
LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly2.cif.gz_B PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.116	286	230	26	311	5	265	8.738E-04	85
LOKIASV2_1503_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	0.130	298	243	29	326	21	300	4.361E-04	85
LOKIASV2_1503_ESMFold_hypothetical_protein	5qtz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5qtz-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYLPYRIDIN-2-YL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-A]PYRIDINE	0.101	290	258	28	315	13	302	1.751E-03	85
LOKIASV2_1503_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	0.120	287	226	28	314	11	268	7.083E-05	85
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.145	284	201	27	310	11	246	2.055E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	0.102	285	223	26	310	12	260	1.847E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.105	296	186	26	321	13	221	2.413E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	0.111	291	226	26	316	9	263	1.948E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.104	298	227	27	324	15	268	2.168E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.100	289	227	27	315	17	269	1.660E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	0.117	298	218	27	324	22	269	5.120E-04	84
LOKIASV2_1503_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	0.121	301	211	26	326	1	241	7.056E-04	84
LOKIASV2_1503_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	0.117	286	230	26	311	6	267	2.545E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	7atu-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7atu-assembly2.cif.gz_B The LIMK1 Kinase Domain Bound To LIJTF500025	0.134	300	229	26	325	10	275	1.204E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	6srh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6srh-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117	0.111	292	249	26	317	7	287	1.340E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	4ump-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4ump-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	0.138	308	216	12	319	1	252	3.715E-04	84
LOKIASV2_1503_ESMFold_hypothetical_protein	4f9a-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4f9a-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and nucleotide	0.094	290	256	15	298	6	295	2.055E-03	84
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly5.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly5.cif.gz_E Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.113	288	224	28	315	11	263	5.697E-04	84
LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.126	281	205	27	307	11	245	2.833E-03	83
LOKIASV2_1503_ESMFold_hypothetical_protein	5v19-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5v19-assembly2.cif.gz_B Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.086	283	222	28	310	15	258	1.573E-03	83
LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.116	299	225	28	326	6	260	1.491E-03	83
LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.118	299	225	28	326	7	262	1.491E-03	83
LOKIASV2_1503_ESMFold_hypothetical_protein	2wei-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2wei-assembly1.cif.gz_A Crystal structure of the kinase domain of Cryptosporidium parvum calcium dependent protein kinase in complex with 3-MB-PP1	0.119	286	225	28	313	20	275	6.010E-04	83
LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	3orx-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.139	301	209	26	326	6	249	1.082E-03	83
LOKIASV2_1503_ESMFold_hypothetical_protein	7qhg-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7qhg-assembly2.cif.gz_B LIM domain kinase 2 (LIMK2) in complex with TH-470	0.119	301	211	26	326	3	243	4.601E-04	83
LOKIASV2_1503_ESMFold_hypothetical_protein	2v7o-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2v7o-assembly1.cif.gz_A Crystal structure of human calcium-calmodulin-dependent protein kinase II gamma	0.112	312	268	14	325	1	303	4.601E-04	83
LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly4.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly4.cif.gz_G Crystal structure of PKCiota in complex with inhibitor	0.112	286	226	26	311	2	256	1.948E-03	83
LOKIASV2_1503_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E Heterodimeric structure of ERK2 and RSK1	0.106	296	259	26	321	18	308	5.120E-04	83
LOKIASV2_1503_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.119	280	181	27	306	8	214	7.443E-04	83
LOKIASV2_1503_ESMFold_hypothetical_protein	3ncg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ncg-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor NM-PP1	0.116	286	221	28	313	15	265	1.142E-03	83
LOKIASV2_1503_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	0.104	300	254	26	325	3	287	7.443E-04	83
LOKIASV2_1503_ESMFold_hypothetical_protein	7kx6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7kx6-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with XMD8-85	0.113	311	215	16	326	4	246	1.082E-03	82
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.122	259	180	26	284	6	211	9.218E-04	82
LOKIASV2_1503_ESMFold_hypothetical_protein	5lvp-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5lvp-assembly4.cif.gz_D Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.142	301	202	26	326	8	243	9.218E-04	82
LOKIASV2_1503_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	0.118	286	226	26	311	6	262	5.380E-03	82
LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.101	291	233	27	317	16	275	1.660E-03	82
LOKIASV2_1503_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.138	299	198	28	326	15	245	5.401E-04	82
LOKIASV2_1503_ESMFold_hypothetical_protein	7xdv-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7xdv-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	0.099	306	251	14	319	4	283	2.287E-03	82
LOKIASV2_1503_ESMFold_hypothetical_protein	5mrd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5mrd-assembly1.cif.gz_A Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket	0.116	286	232	26	311	6	268	1.660E-03	82
LOKIASV2_1503_ESMFold_hypothetical_protein	5s78-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5s78-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010934a	0.114	291	243	27	317	10	284	9.724E-04	82
LOKIASV2_1503_ESMFold_hypothetical_protein	4ytc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4ytc-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease	0.132	293	240	27	319	8	284	2.685E-03	82
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly4.cif.gz_D Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.107	287	219	26	312	6	251	4.853E-04	82
LOKIASV2_1503_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	0.095	300	205	27	326	14	241	9.218E-04	82
LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly2.cif.gz_C Crystal structure of PKCiota in complex with inhibitor	0.103	286	227	26	311	2	255	2.168E-03	82
LOKIASV2_1503_ESMFold_hypothetical_protein	2i0e-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2i0e-assembly1.cif.gz_A Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor	0.126	301	238	26	326	3	275	8.283E-04	82
LOKIASV2_1503_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_B Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.118	281	212	26	306	8	248	4.344E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3	LOKIASV2_1503_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	0.101	283	220	28	310	14	259	2.413E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	6c19-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6c19-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN36985	0.127	301	218	24	324	12	262	1.660E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_C Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.133	301	211	26	326	8	251	8.704E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	4nks-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4nks-assembly2.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3	0.110	298	223	27	324	20	270	9.724E-04	81
LOKIASV2_1503_ESMFold_hypothetical_protein	8xfm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8xfm-assembly1.cif.gz_A The Crystal Structure of MNK2 from Biortus.	0.114	287	234	27	313	11	275	9.724E-04	81
LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.108	298	233	27	324	18	279	2.685E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.112	298	232	27	324	19	280	2.833E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	3gxl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3gxl-assembly1.cif.gz_A ALK-5 kinase complex with GW857175	0.121	286	241	28	313	9	283	1.573E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	6hvd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6hvd-assembly1.cif.gz_A Human SLK bound to a maleimide inhibitor	0.124	290	227	28	317	21	280	3.152E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_C CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	0.112	313	226	14	326	1	255	5.401E-04	81
LOKIASV2_1503_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A CDK1/CyclinB1/CKS2 in complex with NU6102	0.115	283	242	28	310	11	285	1.948E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	0.114	289	232	27	315	26	288	2.287E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly7.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly7.cif.gz_G Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.119	285	204	26	310	5	237	1.026E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor	0.134	306	216	14	319	1	250	4.853E-04	81
LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly3.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly3.cif.gz_E Crystal structure of PKCiota in complex with inhibitor	0.111	286	225	26	311	1	254	2.685E-03	81
LOKIASV2_1503_ESMFold_hypothetical_protein	6gvx-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6gvx-assembly2.cif.gz_B Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK) in complex with dorsomorphin (Compound C)	0.133	311	220	9	319	2	256	4.853E-04	81
LOKIASV2_1503_ESMFold_hypothetical_protein	4ian-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4ian-assembly1.cif.gz_B Crystal Structure of apo Human PRPF4B kinase domain	0.098	304	255	28	311	16	319	8.738E-04	81
LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6qau-assembly2.cif.gz_C Crystal structure of ULK2 in complexed with MRT67307	0.120	295	194	28	322	15	235	8.283E-04	80
LOKIASV2_1503_ESMFold_hypothetical_protein	4bid-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4bid-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.103	299	206	28	326	15	245	3.152E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	0.099	289	215	27	315	10	249	1.026E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	3nax-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3nax-assembly1.cif.gz_A PDK1 in complex with inhibitor MP7	0.125	294	231	26	319	6	270	2.413E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	5d9k-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5d9k-assembly2.cif.gz_B Rsk2 N-terminal Kinase in Complex with BI-D1870	0.141	292	218	27	318	10	264	2.055E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	0.123	276	176	26	301	6	207	3.904E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A Structure of PDK1-S241A mutant kinase domain	0.119	286	231	26	311	10	272	1.491E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	0.102	300	243	27	326	16	287	3.152E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLEX WITH 3-AMINO-6- [4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE	0.119	290	253	28	315	13	302	1.340E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	5dvr-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5dvr-assembly1.cif.gz_A Crystal Structure of TgCDPK1 From Toxoplasma Gondii complexed with GW780159X	0.117	284	222	28	311	12	263	1.204E-03	80
LOKIASV2_1503_ESMFold_hypothetical_protein	3coh-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3coh-assembly2.cif.gz_B Crystal structure of Aurora-A in complex with a pentacyclic inhibitor	0.092	301	203	26	326	7	231	4.118E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly2.cif.gz_C BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	0.099	292	210	28	319	18	251	5.380E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	0.097	288	220	26	313	7	251	3.152E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	2x9f-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2x9f-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.107	297	219	28	324	12	257	2.988E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	0.135	301	216	26	326	7	257	1.751E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	8a66-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8a66-assembly1.cif.gz_A Crystal structure of MST2 in complex with XMU-MP-1	0.092	299	243	27	325	4	272	4.344E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	0.102	299	230	27	325	8	264	2.685E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	3otu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3otu-assembly1.cif.gz_A PDK1 mutant bound to allosteric disulfide fragment activator JS30	0.114	287	228	26	312	5	262	2.833E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7g-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7g-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b	0.106	275	177	27	301	5	203	4.834E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	6gu6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6gu6-assembly1.cif.gz_A CDK1/Cks2 in complex with Dinaciclib	0.109	289	184	28	316	8	215	7.443E-04	79
LOKIASV2_1503_ESMFold_hypothetical_protein	5s87-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5s87-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010953a	0.113	276	185	26	301	3	212	2.685E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	0.102	290	251	27	316	9	289	1.026E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin	0.123	285	225	26	310	7	264	1.660E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	5eak-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5eak-assembly1.cif.gz_A Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.101	295	221	25	319	8	254	8.738E-04	79
LOKIASV2_1503_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	0.113	292	234	27	318	10	274	7.443E-04	79
LOKIASV2_1503_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	0.103	299	259	26	324	8	297	7.852E-04	79
LOKIASV2_1503_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	0.125	301	234	26	326	11	278	2.545E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9f-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6c9f-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	0.116	285	224	27	311	8	261	1.204E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	0.091	296	235	27	322	10	268	3.508E-03	79
LOKIASV2_1503_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	0.133	293	224	28	320	26	284	8.283E-04	79
LOKIASV2_1503_ESMFold_hypothetical_protein	3zfm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3zfm-assembly1.cif.gz_A Crystal structure of EphB2	0.120	297	194	27	323	19	240	1.414E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	4bid-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4bid-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.098	206	118	28	233	15	146	7.822E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	0.116	289	184	27	315	13	221	3.325E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovi-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ovi-assembly1.cif.gz_A Protein kinase MKK7 in complex with phenethyltriazole-substituted pyrazolopyrimidine	0.116	299	207	26	324	18	252	8.738E-04	78
LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.134	301	212	26	326	8	253	5.987E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	4iti-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4iti-assembly2.cif.gz_B Crystal structure of RIP1 kinase in complex with necrostatin-3 analog	0.118	289	228	29	317	11	269	2.168E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.119	298	220	28	325	12	262	2.685E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	4l00-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4l00-assembly3.cif.gz_B Crystal structure of the apo Jak1 pseudokinase domain	0.093	292	231	28	319	23	278	5.380E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	2vu3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2vu3-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	0.118	289	173	28	316	8	204	2.833E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.112	301	241	26	326	15	286	4.344E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole	0.136	292	228	27	318	10	274	1.948E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	0.098	290	238	24	313	20	284	4.118E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	6cth-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6cth-assembly1.cif.gz_A Crystal Structure of Pathogenesis-related Protein 1G (PR-1G) Kinase Domain from Cacao	0.104	302	245	17	318	8	281	7.028E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	2i0e-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2i0e-assembly2.cif.gz_B Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor	0.127	287	228	26	312	3	264	2.413E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_A Kinase and Ubiquitin-associated domains of MARK3/Par-1	0.117	292	223	27	318	15	267	2.055E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6ilz-assembly1.cif.gz_A Crystal structure of PKCiota in complex with inhibitor	0.119	301	234	26	326	2	268	3.508E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	5n3f-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5n3f-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule N-[3-(aminomethyl)phenyl]acetamide	0.108	291	228	28	318	38	294	1.142E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	6ya8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6ya8-assembly1.cif.gz_A Cdc7-Dbf4 bound to ADP-BeF3	0.090	332	269	15	311	7	338	3.325E-03	78
LOKIASV2_1503_ESMFold_hypothetical_protein	3mwu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3mwu-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor RM-1-95	0.120	288	224	26	313	12	266	5.697E-04	78
LOKIASV2_1503_ESMFold_hypothetical_protein	8sap-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8sap-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase ThurKC	0.128	278	231	10	287	178	443	1.419E-04	78
LOKIASV2_1503_ESMFold_hypothetical_protein	2h34-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2h34-assembly2.cif.gz_B Apoenzyme crystal structure of the tuberculosis serine/threonine kinase, PknE	0.100	289	212	27	315	3	239	2.685E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5v24-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5v24-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.096	285	213	26	310	12	248	3.508E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	4bf2-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4bf2-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.100	294	176	25	318	11	207	4.583E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	6e2n-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6e2n-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	0.093	283	225	28	310	15	263	4.118E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	0.135	301	218	26	326	9	261	3.152E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	1zxe-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	1zxe-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.101	301	218	26	326	7	249	2.685E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b	0.106	297	220	28	324	22	268	6.340E-04	77
LOKIASV2_1503_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.114	298	228	27	324	17	274	7.028E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	3qc4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3qc4-assembly1.cif.gz_A PDK1 in complex with DFG-OUT inhibitor xxx	0.126	287	224	26	312	6	262	1.660E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.105	291	228	27	317	17	272	5.987E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5ime-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5ime-assembly2.cif.gz_B Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9	0.126	318	211	9	326	8	249	2.545E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5a14-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5a14-assembly1.cif.gz_A Human CDK2 with type II inhibitor	0.099	291	239	26	316	6	271	1.270E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5hvj-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5hvj-assembly2.cif.gz_B Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.124	300	201	27	326	12	242	1.142E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	0.113	285	227	26	310	9	265	2.413E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7w-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7w-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h	0.108	292	247	26	317	6	283	2.413E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5s8b-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5s8b-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010960a	0.121	292	243	26	317	7	283	3.508E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	0.128	301	214	26	326	11	256	2.287E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	0.118	301	210	26	326	19	257	5.675E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7v-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7v-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010942a	0.097	276	190	26	301	3	213	3.152E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_B-2	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	0.114	292	256	26	317	3	292	1.270E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	0.102	300	242	27	326	9	279	1.847E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5twy-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5twy-assembly1.cif.gz_A Structure of Maternal Embryonic Leucine Zipper Kinase	0.135	301	210	12	312	2	245	3.522E-04	77
LOKIASV2_1503_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.114	292	234	27	318	10	274	1.340E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	4ump-assembly1.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	4ump-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	0.148	305	222	15	319	3	264	6.340E-04	77
LOKIASV2_1503_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	0.121	292	232	27	318	10	274	2.287E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A Structure of a Par3-inhibitory peptide bound to PKCiota core kinase domain	0.116	301	239	26	326	10	280	2.545E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	7myj-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7myj-assembly2.cif.gz_C Structure of full length human AMPK (a2b1g1) in complex with a small molecule activator MSG011	0.109	300	240	27	326	11	280	1.948E-03	77
LOKIASV2_1503_ESMFold_hypothetical_protein	5tkd-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5tkd-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	0.111	300	200	27	326	12	237	8.251E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	2z7q-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2z7q-assembly1.cif.gz_A Crystal structure of the N-terminal kinase domain of human RSK-1 bound to AMP-PCP	0.142	300	205	27	326	10	249	1.751E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	0.101	279	226	26	304	9	260	3.701E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	2y4i-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2y4i-assembly1.cif.gz_B KSR2-MEK1 heterodimer	0.097	292	222	28	319	18	264	6.316E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw9-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	2iw9-assembly1.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.120	284	221	28	311	9	260	3.152E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	0.117	283	211	28	310	21	260	9.686E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	4qqc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4qqc-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain in Complex with FIIN-2, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR Kinase Gate-Keeper Mutations	0.119	298	216	27	324	27	272	2.685E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dibenzonaphthyridine inhibitor	0.117	287	223	26	312	7	259	5.120E-04	76
LOKIASV2_1503_ESMFold_hypothetical_protein	7umb-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7umb-assembly1.cif.gz_B NanoBRET tracer Tram-bo bound to a KSR2-MEK1 complex	0.106	292	232	26	317	14	273	6.663E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	6i2y-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6i2y-assembly1.cif.gz_A Human STK10 bound to Foretinib	0.110	298	230	28	325	17	275	1.414E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23	0.123	287	225	26	312	5	261	9.218E-04	76
LOKIASV2_1503_ESMFold_hypothetical_protein	2vz6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2vz6-assembly1.cif.gz_A Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.096	300	257	27	326	7	291	2.413E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	3q53-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3q53-assembly1.cif.gz_A Structure of phosphorylated PAK1 kinase domain in complex with ATP	0.106	317	249	9	325	8	287	4.834E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.121	299	188	26	324	2	216	6.010E-04	76
LOKIASV2_1503_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with LJH685	0.135	292	229	27	318	19	284	1.270E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B Crystal structure of CaMKII-actinin complex bound to ADP	0.112	300	252	26	325	10	294	4.601E-04	76
LOKIASV2_1503_ESMFold_hypothetical_protein	2jdo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2jdo-assembly1.cif.gz_A STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE	0.110	292	234	27	318	10	273	5.675E-03	76
LOKIASV2_1503_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A Complex of Aurora-A bound to an Imidazopyridine-based inhibitor	0.086	288	213	26	313	9	242	9.182E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzf-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzf-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	0.096	301	207	26	326	9	238	7.414E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	8s98-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8s98-assembly1.cif.gz_A Crystal structure of the TYK2 pseudokinase domain in complex with compound 8	0.107	300	206	27	326	15	246	6.663E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	2z7s-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2z7s-assembly1.cif.gz_A Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Purvalnol A	0.143	300	206	27	326	10	250	1.948E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	8s9a-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	8s9a-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with TAK-279	0.106	291	219	27	317	15	260	7.028E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	8tb6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8tb6-assembly1.cif.gz_A TYK2 JH2 bound to Compound14	0.100	291	217	27	317	19	260	5.987E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	6e2o-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6e2o-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	0.109	283	221	28	310	15	263	2.988E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	1zy5-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1zy5-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: R794G Hyperactivating Mutant Complexed with AMPPNP.	0.101	298	209	28	325	12	244	3.508E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A FGFR4 complex with N-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide	0.129	298	220	27	324	17	270	8.738E-04	75
LOKIASV2_1503_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Cdk2 inhibitor IV	0.151	306	218	21	326	4	261	2.168E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	0.119	292	233	24	315	8	272	5.987E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	5jq5-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5jq5-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor ICEC0942	0.118	208	116	28	235	6	137	9.686E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	8x5z-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8x5z-assembly1.cif.gz_A The Crystal Structure of PAK1 kinase domain from Biortus.	0.118	317	239	9	325	9	280	2.685E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP	0.121	290	233	28	317	11	276	1.026E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	3mtl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3mtl-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with Indirubin E804	0.142	300	214	27	326	7	256	7.056E-04	75
LOKIASV2_1503_ESMFold_hypothetical_protein	8xfl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8xfl-assembly1.cif.gz_A The Crystal Structure of MARK4 from Biortus.	0.110	293	215	26	318	5	247	5.401E-04	75
LOKIASV2_1503_ESMFold_hypothetical_protein	5maf-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5maf-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.148	301	210	15	315	4	250	2.844E-04	75
LOKIASV2_1503_ESMFold_hypothetical_protein	3iw4-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3iw4-assembly2.cif.gz_B Crystal structure of PKC alpha in complex with NVP-AEB071	0.121	291	230	28	318	12	274	1.340E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9h-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6c9h-assembly1.cif.gz_A non-phosphorylated AMP-activated protein kinase bound to pharmacological activator R734	0.112	285	223	27	311	10	261	1.847E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	5ezv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5ezv-assembly1.cif.gz_A X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.103	294	233	27	320	11	271	2.055E-03	75
LOKIASV2_1503_ESMFold_hypothetical_protein	6e2m-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6e2m-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	0.100	287	212	25	311	11	247	3.904E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	6nsl-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nsl-assembly2.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound-6c AKA 6-((1-(4-CYANOPHENY L)-2-OXO-1,2-DIHYDRO-3-PYRIDINYL)AMINO)-N-CYCLOPROPYL-8-(M ETHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBOXAMIDE	0.094	300	205	27	326	12	238	1.200E-02	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3vw6-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3vw6-assembly1.cif.gz_B Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibitor	0.101	285	216	26	310	12	252	6.316E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	6xih-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6xih-assembly1.cif.gz_A Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile	0.101	283	218	28	310	14	256	8.704E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3zxt-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3zxt-assembly2.cif.gz_C Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.096	284	225	27	310	9	258	1.335E-02	74
LOKIASV2_1503_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A crystal structure of an inactive Akt2 kinase domain	0.088	284	202	27	310	9	230	1.573E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3a62-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3a62-assembly1.cif.gz_A Crystal structure of phosphorylated p70S6K1	0.143	292	208	27	318	10	253	4.344E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	2z7r-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2z7r-assembly1.cif.gz_A Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Staurosporine	0.132	300	214	27	326	13	259	1.751E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	0.099	298	223	27	324	9	256	8.251E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	0.110	306	223	19	324	13	264	2.833E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	6qav-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6qav-assembly1.cif.gz_B Crystal structure of ULK2 in complexed with MRT68921	0.134	298	209	29	326	15	256	2.545E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	5nxd-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5nxd-assembly2.cif.gz_B LIM Domain Kinase 2 (LIMK2) In Complex With TH-300	0.117	301	203	26	326	1	231	1.948E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	5vio-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5vio-assembly4.cif.gz_D Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 13)	0.094	302	223	25	326	12	258	6.316E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3zhp-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3zhp-assembly2.cif.gz_C Human MST3 (STK24) in complex with MO25beta	0.115	299	228	27	325	11	269	3.152E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	5d9k-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5d9k-assembly1.cif.gz_A Rsk2 N-terminal Kinase in Complex with BI-D1870	0.144	292	217	27	318	10	263	2.833E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg0-assembly1.cif.gz_A Crystal structure of S287D,T291D MKK7 (MAP2K7), apo form	0.104	299	226	26	324	18	270	1.847E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_A Crystal Structure of the Human Ribosomal protein S6 kinase	0.113	286	216	28	313	7	251	2.685E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	0.099	300	248	14	313	7	282	2.988E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	6t6d-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6t6d-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	0.115	276	180	26	301	5	208	4.118E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	4yc6-assembly4.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	4yc6-assembly4.cif.gz_G CDK1/CKS1	0.120	289	181	28	316	8	214	2.685E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site	0.110	285	232	26	310	8	269	6.316E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	0.114	284	247	27	310	7	286	1.948E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	0.106	291	233	27	317	21	282	7.414E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A TGF-beta Receptor type 1 in complex with SB431542	0.135	274	179	28	301	10	217	4.344E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.138	308	228	12	319	1	265	2.696E-04	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3qkm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3qkm-assembly1.cif.gz_A Spirocyclic sulfonamides as AKT inhibitors	0.109	292	235	27	318	10	274	2.545E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_A MRCK beta in complex with fasudil	0.113	306	261	15	320	61	355	1.751E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_B MRCK beta in complex with fasudil	0.137	318	271	9	326	55	369	1.204E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	5iso-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5iso-assembly1.cif.gz_A STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR, A BENZIMIDAZOLE DERIVATIVE (991)	0.107	293	231	27	319	10	269	1.751E-03	74
LOKIASV2_1503_ESMFold_hypothetical_protein	7ydx-assembly1.cif.gz_B-2	LOKIASV2_1503_ESMFold_hypothetical_protein	7ydx-assembly1.cif.gz_B-2 Crystal structure of human RIPK1 kinase domain in complex with compound RI-962	0.117	294	185	29	322	9	218	5.380E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfm-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4cfm-assembly2.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	0.121	298	213	28	325	9	251	4.583E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	7uos-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7uos-assembly1.cif.gz_A Structure of WNK1 inhibitor complex	0.103	284	229	28	311	15	270	4.118E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	8pm3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8pm3-assembly1.cif.gz_A Crystal structure of MAP2K6 with a covalent compound GCL94	0.113	299	230	26	324	6	265	5.401E-04	73
LOKIASV2_1503_ESMFold_hypothetical_protein	4wnp-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4wnp-assembly3.cif.gz_C Structure of ULK1 bound to a potent inhibitor	0.131	299	215	28	326	13	260	5.675E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Z902-A3	0.137	299	213	28	326	14	261	2.833E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	0.101	298	236	27	324	17	279	1.078E-02	73
LOKIASV2_1503_ESMFold_hypothetical_protein	7qhg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7qhg-assembly1.cif.gz_A LIM domain kinase 2 (LIMK2) in complex with TH-470	0.107	300	242	26	325	2	273	6.663E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	3ri1-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3ri1-assembly2.cif.gz_B Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	0.105	301	241	24	324	11	280	7.822E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	0.109	303	244	24	326	11	285	8.251E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.100	289	240	27	315	16	283	1.573E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpy-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5lpy-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ATP from Arabidopsis thaliana	0.119	300	245	14	313	6	284	2.168E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	7up5-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	0.116	283	202	29	311	17	246	1.948E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7o-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7o-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c	0.113	292	247	26	317	7	286	4.118E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)	0.097	299	237	27	325	21	283	4.118E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	3s95-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3s95-assembly2.cif.gz_B Crystal structure of the human LIMK1 kinase domain in complex with staurosporine	0.161	301	199	26	326	11	248	3.508E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.131	287	230	26	312	7	272	1.204E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.115	298	242	27	324	17	290	9.724E-04	73
LOKIASV2_1503_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid	0.113	298	237	27	324	22	289	2.685E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	5s76-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5s76-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010916a	0.114	290	253	26	315	3	289	5.100E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	6t6d-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6t6d-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	0.122	275	181	27	301	8	214	9.182E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK22 at F80C	0.111	299	230	28	326	13	272	1.751E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	2wot-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2wot-assembly1.cif.gz_A ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridin-2-amine	0.110	297	257	28	324	12	301	2.685E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A Cdk2(F80C)	0.129	208	122	28	235	13	153	8.251E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	7n93-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7n93-assembly2.cif.gz_B P70 S6K1 IN COMPLEX WITH MSC2363318A-1	0.133	300	223	27	326	10	267	3.701E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	6fyv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6fyv-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A	0.113	319	255	24	312	9	327	1.847E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	0.176	126	99	28	148	16	141	3.686E-02	73
LOKIASV2_1503_ESMFold_hypothetical_protein	7nh5-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7nh5-assembly1.cif.gz_A Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 6	0.109	301	225	18	318	104	356	1.204E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	3qfv-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3qfv-assembly1.cif.gz_B MRCK beta in complex with TPCA-1	0.114	316	262	9	324	55	351	2.413E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	3fbv-assembly1.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	3fbv-assembly1.cif.gz_D Crystal structure of the oligomer formed by the kinase-ribonuclease domain of Ire1	0.092	129	112	28	156	16	139	1.653E-02	73
LOKIASV2_1503_ESMFold_hypothetical_protein	5iso-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5iso-assembly2.cif.gz_C STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR, A BENZIMIDAZOLE DERIVATIVE (991)	0.113	300	238	21	320	2	270	3.508E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A Crystal Structure and Allosteric Activation of Protein Kinase C beta II	0.105	301	243	26	326	195	467	3.152E-03	73
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_40 AKA 6-cyclopropaneamido-4-[(2-methanesulfonylphenyl)amino]-N-methylpyridine-3-carboxamide	0.102	300	205	27	326	12	240	1.408E-02	72
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ovk-assembly1.cif.gz_A Protein kinase MKK7 in complex with 5-bromo-2-hydroxyphenyl-substituted pyrazolopyrimidine	0.118	299	202	26	324	18	247	1.847E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	4fk3-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4fk3-assembly3.cif.gz_B B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	0.099	297	218	28	324	14	256	4.834E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	4rlp-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4rlp-assembly1.cif.gz_A Human p70s6k1 with ruthenium-based inhibitor FL772	0.120	277	187	28	304	11	223	4.834E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	3zon-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3zon-assembly1.cif.gz_A Human TYK2 pseudokinase domain bound to a kinase inhibitor	0.114	300	206	27	326	16	248	2.685E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	3a60-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3a60-assembly1.cif.gz_A Crystal structure of unphosphorylated p70S6K1 (Form I)	0.128	299	189	27	325	10	227	3.508E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	6vvg-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6vvg-assembly1.cif.gz_B Structure of the Cydia pomonella Granulovirus kinase, PK-1	0.085	296	236	15	310	5	263	1.265E-02	72
LOKIASV2_1503_ESMFold_hypothetical_protein	3zhp-assembly1.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	3zhp-assembly1.cif.gz_D Human MST3 (STK24) in complex with MO25beta	0.110	299	227	27	325	5	260	4.583E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A MST3 in complex with compound MRIA9	0.090	299	227	27	325	11	261	5.100E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg3-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1	0.100	299	216	26	324	17	257	2.833E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	6qfr-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qfr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 dfg-out conformation	0.113	299	214	26	324	18	259	2.168E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	2vtq-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2vtq-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	0.115	289	164	28	316	8	193	1.751E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873	0.096	283	185	28	310	8	213	3.701E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B Crystal Structure of activated receptor tyrosine kinase in complex with substrates	0.115	289	218	27	315	18	264	4.118E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	0.125	301	214	26	326	8	253	7.028E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB	LOKIASV2_1503_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	0.105	300	234	27	326	17	278	7.028E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	7xdx-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7xdx-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	0.090	303	248	15	317	6	279	1.200E-02	72
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovn-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ovn-assembly1.cif.gz_A Protein kinase MKK7 in complex with tolyl-substituted indazole	0.114	304	229	21	324	15	273	1.082E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	4hni-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4hni-assembly1.cif.gz_A crystal structure of ck1e in complex with PF4800567	0.141	300	227	27	326	9	273	8.738E-04	72
LOKIASV2_1503_ESMFold_hypothetical_protein	6lvl-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6lvl-assembly2.cif.gz_B Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	0.121	303	242	24	326	11	286	6.663E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7z-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7z-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074488b	0.111	292	249	26	317	6	286	5.987E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.110	284	243	28	311	8	281	5.100E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	6yz4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yz4-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) with ibrutinib bound at allosteric site	0.121	299	228	26	324	19	278	1.082E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.116	297	219	28	324	8	256	5.380E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	1yhv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1yhv-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E)	0.118	318	223	9	326	9	262	5.100E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents	0.127	208	120	28	235	8	145	2.675E-02	72
LOKIASV2_1503_ESMFold_hypothetical_protein	6fha-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6fha-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289A and S308A mutations	0.104	300	243	26	325	11	282	2.988E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR	0.103	289	215	27	315	9	249	1.847E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	5y90-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5y90-assembly1.cif.gz_A MAP2K7 mutant -C218S	0.120	299	231	26	324	17	279	7.852E-04	72
LOKIASV2_1503_ESMFold_hypothetical_protein	6bdn-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6bdn-assembly1.cif.gz_A Crystal structure of human TAO3 kinase binding ADP	0.097	310	259	16	325	2	289	3.152E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.110	300	205	27	326	8	238	2.833E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	5twz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5twz-assembly1.cif.gz_A Structure of Maternal Embryonic Leucine Zipper Kinase	0.119	297	211	15	311	4	244	1.847E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	4l45-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4l45-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389E	0.139	299	222	27	325	14	272	2.685E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	4dc2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4dc2-assembly1.cif.gz_A Structure of PKC in Complex with a Substrate Peptide from Par-3	0.115	301	239	26	326	7	277	5.380E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	7k7z-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7k7z-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.109	290	243	26	315	161	434	3.701E-03	72
LOKIASV2_1503_ESMFold_hypothetical_protein	6n3l-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6n3l-assembly1.cif.gz_A Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents	0.119	283	193	27	309	10	229	6.316E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	8tb6-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8tb6-assembly2.cif.gz_B TYK2 JH2 bound to Compound14	0.112	300	205	27	326	13	244	1.335E-02	71
LOKIASV2_1503_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B The ROR1 Pseudokinase Domain Bound To Ponatinib	0.101	290	218	28	317	13	255	2.685E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	4fg8-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4fg8-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-315 in complex with ATP	0.114	301	200	26	326	8	234	1.948E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	5auw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5auw-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with quercetin.	0.105	285	232	26	310	13	272	1.137E-02	71
LOKIASV2_1503_ESMFold_hypothetical_protein	4itj-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4itj-assembly2.cif.gz_B Crystal structure of RIP1 kinase in complex with necrostatin-4	0.107	292	237	26	317	10	275	8.251E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovj-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ovj-assembly1.cif.gz_A Protein kinase MKK7 in complex with difluoro-phenethyltriazole-substituted pyrazolopyrimidine	0.132	304	217	21	324	15	265	1.660E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	3rak-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3rak-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-32	0.104	283	185	28	310	8	215	2.833E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2hak-assembly2.cif.gz_B Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.117	284	188	27	310	10	223	4.344E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	6mzw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6mzw-assembly1.cif.gz_A TAS-120 covalent complex with FGFR1	0.106	298	232	27	324	17	277	2.988E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	0.120	298	233	27	324	16	281	9.686E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	6gu7-assembly4.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	6gu7-assembly4.cif.gz_G CDK1/Cks2 in complex with AZD5438	0.127	289	176	28	316	8	210	5.987E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23	0.128	300	235	27	326	12	282	1.751E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	0.106	299	232	28	326	7	267	1.948E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	5s7l-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5s7l-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010943a	0.112	291	243	27	317	11	285	3.701E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	4u44-assembly2.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4u44-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 16)	0.118	297	235	28	324	18	285	1.270E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	4hok-assembly13.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	4hok-assembly13.cif.gz_E crystal structure of apo ck1e	0.142	289	227	27	315	11	275	1.660E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	6hxf-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6hxf-assembly1.cif.gz_B Human STK10 bound to a maleimide inhibitor	0.120	299	241	28	326	17	291	7.443E-04	71
LOKIASV2_1503_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527	0.100	298	242	27	324	21	290	4.834E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B P70 S6K1 IN COMPLEX WITH MSC2317067A-1	0.126	286	214	27	312	10	255	3.904E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	3zh8-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3zh8-assembly3.cif.gz_C A novel small molecule aPKC inhibitor	0.107	300	238	26	325	8	275	5.675E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	0.109	301	236	26	326	10	275	7.028E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.106	309	253	17	325	8	291	3.152E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	5t5t-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5t5t-assembly1.cif.gz_A AMPK bound to allosteric activator	0.118	295	231	27	321	10	272	3.701E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B Crystal structure of KA1-autoinhibited MARK1 kinase	0.125	262	203	27	288	10	242	4.344E-03	71
LOKIASV2_1503_ESMFold_hypothetical_protein	1ol6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1ol6-assembly1.cif.gz_A Structure of unphosphorylated D274N mutant of Aurora-A	0.088	301	203	26	326	7	230	6.316E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	2xne-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2xne-assembly1.cif.gz_A Structure of Aurora-A bound to an imidazopyrazine inhibitor	0.092	288	216	26	313	6	244	1.486E-02	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzf-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzf-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	0.101	300	203	27	326	13	239	8.704E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg4-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with K00007	0.118	301	214	26	326	17	260	2.685E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H	LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H Crystal structure of EphB1	0.109	298	222	27	324	9	258	9.686E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	8bzi-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8bzi-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with inhibitor MR39	0.087	299	226	27	325	14	262	7.414E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_B Crystal structure of JAK2 JH2-K539L	0.145	301	210	26	326	9	255	6.316E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	1gzo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1gzo-assembly1.cif.gz_A Structure of protein kinase B unphosphorylated	0.117	290	215	26	315	6	249	7.822E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	2vtt-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2vtt-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	0.120	284	223	28	311	8	261	4.583E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	5auu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5auu-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with luteolin.	0.141	301	213	26	326	13	261	1.078E-02	70
LOKIASV2_1503_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A Crystal Structure of the E596A V617F Mutant JAK2 Pseudokinase Domain Bound to Mg-ATP	0.146	299	211	28	326	13	260	3.904E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	7jus-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7jus-assembly1.cif.gz_B Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib	0.097	292	233	26	317	14	272	1.200E-02	70
LOKIASV2_1503_ESMFold_hypothetical_protein	2pe0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2pe0-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-1,3-dihydro-indol-2-one COMPLEX	0.123	299	193	26	324	8	228	2.545E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6qg7-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qg7-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1k	0.135	299	221	26	324	18	273	1.573E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 11	0.125	301	212	26	326	11	253	5.380E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5lpv-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with AMPPNP and Mn from Arabidopsis thaliana	0.119	300	244	14	313	6	283	4.344E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6hxf-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6hxf-assembly4.cif.gz_D Human STK10 bound to a maleimide inhibitor	0.114	292	238	28	319	18	287	7.852E-04	70
LOKIASV2_1503_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.109	301	242	24	324	12	284	1.137E-02	70
LOKIASV2_1503_ESMFold_hypothetical_protein	3bhh-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3bhh-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)	0.096	300	256	26	325	4	287	5.100E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6ib0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6ib0-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3a	0.104	299	236	26	324	19	282	1.660E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.104	300	244	27	326	7	279	2.545E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	0.098	303	245	24	326	21	293	4.834E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	5z1e-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5z1e-assembly1.cif.gz_A MAP2K7 C218S mutant-inhibitor	0.120	299	222	26	324	17	269	1.340E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	0.117	294	215	26	319	5	248	1.026E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	0.117	298	247	27	324	20	300	1.026E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	3iec-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3iec-assembly2.cif.gz_B Helicobacter pylori CagA Inhibits PAR1/MARK Family Kinases by Mimicking Host Substrates	0.126	291	184	26	316	4	215	4.583E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B X-ray crystal structure of NDR1 kinase domain	0.121	291	193	27	317	10	229	2.988E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	3iw4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3iw4-assembly1.cif.gz_A Crystal structure of PKC alpha in complex with NVP-AEB071	0.126	301	238	26	326	8	280	4.118E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.094	289	259	26	312	19	307	6.663E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6e4t-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6e4t-assembly1.cif.gz_A Structure of AMPK bound to activator	0.108	294	234	21	314	2	264	3.152E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9j-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6c9j-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	0.116	296	228	27	322	10	268	3.701E-03	70
LOKIASV2_1503_ESMFold_hypothetical_protein	8sap-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8sap-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase ThurKC	0.139	279	225	9	287	191	452	7.852E-04	70
LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	0.106	291	218	27	317	15	259	1.078E-02	69
LOKIASV2_1503_ESMFold_hypothetical_protein	6fdz-assembly1.cif.gz_U	LOKIASV2_1503_ESMFold_hypothetical_protein	6fdz-assembly1.cif.gz_U Unc-51-Like Kinase 3 (ULK3) In Complex With Momelotinib	0.129	298	206	28	325	11	248	9.182E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	7b36-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7b36-assembly1.cif.gz_A MST4 in complex with compound G-5555	0.113	299	220	27	325	10	258	2.833E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	7kl2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7kl2-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B(S1303D)	0.107	287	233	26	312	6	267	1.137E-02	69
LOKIASV2_1503_ESMFold_hypothetical_protein	2xvd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2xvd-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.102	299	226	26	324	10	262	1.265E-02	69
LOKIASV2_1503_ESMFold_hypothetical_protein	4eor-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4eor-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	0.113	287	221	28	314	9	258	9.686E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	5nxc-assembly1.cif.gz_L	LOKIASV2_1503_ESMFold_hypothetical_protein	5nxc-assembly1.cif.gz_L LIM Domain Kinase 1 (LIMK1) In Complex With PF-00477736	0.143	301	194	26	326	11	237	5.380E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	4eoq-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4eoq-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with ATP	0.127	284	223	28	311	12	267	4.834E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	3wf6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3wf6-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1H-indol-3-yl)-3,6-dihydropyridin-1(2H)-yl]-1H-pyrazolo[3,4-d]pyrimidine	0.135	295	227	24	318	3	265	3.508E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	3a7f-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3a7f-assembly1.cif.gz_A Human MST3 kinase	0.100	307	241	19	325	8	276	5.380E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor	0.109	289	176	28	316	8	205	8.704E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg2-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with ibrutnib, with covalent and allosteric binding modes	0.108	299	232	26	324	18	278	3.325E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23	0.121	295	243	27	321	14	291	1.026E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	3f5x-assembly1.cif.gz_A-3	LOKIASV2_1503_ESMFold_hypothetical_protein	3f5x-assembly1.cif.gz_A-3 CDK-2-Cyclin complex with indazole inhibitor 9 bound at its active site	0.111	263	183	28	290	8	214	7.822E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.120	299	219	28	326	22	271	7.028E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	4oh4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4oh4-assembly1.cif.gz_A Crystal structure of BRI1 in complex with BKI1	0.116	300	248	14	313	21	301	2.833E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B Crystal Structure of the Auto-Inhibited Kinase Domain of Calcium/Calmodulin Activated Kinase II	0.120	301	216	26	326	6	251	7.822E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	6npz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6npz-assembly1.cif.gz_A Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	0.118	292	233	27	318	12	276	4.118E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_B Structure of the N-terminal domain of SAD	0.124	287	210	27	313	14	254	2.988E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	6khd-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6khd-assembly2.cif.gz_B Crystal structure of CLK1 in complex with CX-4945	0.125	313	249	28	312	17	329	1.270E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	7e75-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7e75-assembly1.cif.gz_A Crystal structure of human ERK2 mutant (G37C)	0.096	296	265	26	321	18	311	2.833E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.115	302	256	17	318	49	338	3.904E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	0.118	289	232	27	315	122	385	9.218E-04	69
LOKIASV2_1503_ESMFold_hypothetical_protein	4zhx-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4zhx-assembly2.cif.gz_C Novel binding site for allosteric activation of AMPK	0.112	294	232	27	320	10	271	5.675E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	0.113	294	231	27	320	10	270	5.987E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	4qox-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4qox-assembly1.cif.gz_A Crystal Structure of CDPK4 from Plasmodium Falciparum, PF3D7_0717500	0.120	286	221	29	314	25	276	8.283E-04	69
LOKIASV2_1503_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A Crystal structure of G protein-coupled receptor kinase 2 in complex with a a rationally designed paroxetine derivative	0.107	290	242	26	315	163	434	7.822E-03	69
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzh-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzh-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_40 AKA 6-cyclopropaneamido-4-[(2-methanesulfonylphenyl)amino]-N-methylpyridine-3-carboxamide	0.110	300	201	27	326	13	239	1.335E-02	68
LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	0.096	288	218	26	313	15	256	1.137E-02	68
LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly2.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly2.cif.gz_D BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	0.104	297	215	28	324	18	258	1.408E-02	68
LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly1.cif.gz_A Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	0.117	293	217	27	319	15	261	5.380E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	3ii5-assembly3.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ii5-assembly3.cif.gz_A The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor	0.109	292	201	28	319	14	240	1.137E-02	68
LOKIASV2_1503_ESMFold_hypothetical_protein	5uq0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5uq0-assembly1.cif.gz_A FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide	0.112	290	219	24	313	12	259	7.822E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	3my5-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3my5-assembly2.cif.gz_C CDk2/cyclinA in complex with DRB	0.119	284	219	28	311	9	258	7.822E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	8qlt-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8qlt-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with inhibitor MR30	0.112	293	225	27	319	15	268	3.140E-02	68
LOKIASV2_1503_ESMFold_hypothetical_protein	4bco-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4bco-assembly2.cif.gz_C Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor	0.132	289	215	28	316	9	257	2.287E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	7bcm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7bcm-assembly1.cif.gz_A The DDR1 Kinase Domain Bound To SR302	0.098	303	231	24	326	4	260	3.904E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	7juz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	0.107	292	228	26	317	14	269	3.152E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	8pm3-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	8pm3-assembly3.cif.gz_C Crystal structure of MAP2K6 with a covalent compound GCL94	0.119	297	225	28	324	11	266	2.055E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7b8w-assembly2.cif.gz_B Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.153	300	219	26	325	9	267	1.265E-02	68
LOKIASV2_1503_ESMFold_hypothetical_protein	4l00-assembly3.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4l00-assembly3.cif.gz_A Crystal structure of the apo Jak1 pseudokinase domain	0.108	301	218	26	326	19	263	9.686E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4	0.100	298	229	27	324	22	276	1.022E-02	68
LOKIASV2_1503_ESMFold_hypothetical_protein	3hrc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3hrc-assembly1.cif.gz_A Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATP	0.126	299	198	26	324	6	232	1.335E-02	68
LOKIASV2_1503_ESMFold_hypothetical_protein	8fko-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8fko-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.108	301	212	26	326	14	252	5.100E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6gtt-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6gtt-assembly1.cif.gz_A Human STK10 bound to BIRB-796	0.100	298	229	28	325	25	279	8.738E-04	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6g78-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6g78-assembly1.cif.gz_A RSK4 N-terminal Kinase Domain S232E in complex with AMP-PNP	0.108	292	223	27	318	23	273	2.833E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_D CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	0.135	318	211	9	326	9	253	1.491E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	4obp-assembly3.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4obp-assembly3.cif.gz_A MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AMINE	0.121	306	242	19	324	9	284	1.948E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.	0.110	298	235	27	324	19	283	6.316E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6qhr-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qhr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1m	0.139	299	222	26	324	19	277	2.055E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	3alo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3alo-assembly1.cif.gz_A Crystal structure of human non-phosphorylated MKK4 kinase domain ternary complex with AMP-PNP and p38 peptide	0.110	301	219	26	326	10	256	2.055E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B FGFR1 in complex with ponatinib.	0.118	298	230	27	324	23	284	6.663E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly6.cif.gz_K	LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly6.cif.gz_K RSK2 N-terminal kinase domain in complex with ORF45	0.116	300	204	26	325	24	255	1.491E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	5kz7-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5kz7-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.117	269	188	26	294	5	218	5.675E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B Crystal structure of unactivated c-KIT in complex with compound	0.134	303	239	24	326	21	297	7.028E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	3mvh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3mvh-assembly1.cif.gz_A Crystal structure of Akt-1-inhibitor complexes	0.114	292	234	27	318	9	273	7.028E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.111	292	235	27	318	10	274	4.583E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6fyo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6fyo-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A	0.133	312	246	28	312	18	329	3.904E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A Structure of a nucleotide-bound form of PKCiota core kinase domain	0.132	293	229	26	318	9	273	7.028E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	4red-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4red-assembly1.cif.gz_B Crystal structure of human AMPK alpha1 KD-AID with K43A mutation	0.126	294	221	27	320	9	262	2.988E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6e4u-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6e4u-assembly1.cif.gz_A Structure of AMPK bound to activator	0.113	302	236	21	322	2	268	7.414E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9g-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6c9g-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R739	0.113	285	223	27	311	10	261	6.316E-03	68
LOKIASV2_1503_ESMFold_hypothetical_protein	8sam-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.114	277	230	15	291	210	470	8.283E-04	68
LOKIASV2_1503_ESMFold_hypothetical_protein	6bx6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6bx6-assembly1.cif.gz_A AMP-Activated protein kinase (AMPK) inhibition by SBI-0206965: alpha 2 kinase domain bound to SBI-0206965	0.130	261	182	27	287	6	215	7.414E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	8sso-assembly2.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	8sso-assembly2.cif.gz_D AurA bound to danusertib and inhibiting monobody Mb2	0.103	301	204	26	326	8	235	2.535E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly2.cif.gz_I	LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly2.cif.gz_I CaMKIINtide Inhibitor Complex	0.108	284	220	28	311	6	253	6.316E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly4.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly4.cif.gz_E CaMKIINtide Inhibitor Complex	0.109	283	220	28	310	5	252	6.663E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg5-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg5-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with ASC69	0.132	299	201	26	324	19	251	2.685E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7b32-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7b32-assembly1.cif.gz_A MST3 in complex with MRIA7	0.118	299	205	27	325	14	246	1.335E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	0.118	283	224	28	310	11	265	5.380E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	3rny-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3rny-assembly3.cif.gz_B Crystal structure of human RSK1 C-terminal kinase domain	0.110	271	202	43	313	14	241	1.078E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	5z1d-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5z1d-assembly1.cif.gz_A MAP2K7 C276S mutant-inhibitor	0.111	299	219	26	324	17	263	7.414E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7jv1-assembly1.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	7jv1-assembly1.cif.gz_D Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1	0.106	291	228	27	317	16	271	3.904E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	1vyz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1vyz-assembly1.cif.gz_A Structure of CDK2 complexed with PNU-181227	0.122	298	222	28	325	8	261	4.834E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_B Crystal structure of human PAS kinase bound to ADP	0.120	282	223	28	309	22	275	1.137E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A CDK2 with compound 14 inhibitor with carboxylate	0.104	299	224	28	326	8	258	3.508E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.112	294	234	24	317	11	275	1.408E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly8.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly8.cif.gz_D Crystal structure of human PAS kinase bound to ADP	0.104	299	211	28	326	22	258	8.251E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7xqk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7xqk-assembly1.cif.gz_A The Crystal Structure of CDK3 and CyclinE1 Complex from Biortus.	0.125	299	234	28	326	6	273	4.118E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	1ung-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1ung-assembly1.cif.gz_A Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	0.105	285	250	27	311	4	283	3.508E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	8ak2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8ak2-assembly1.cif.gz_A Drosophila melanogaster UNC89 Protein Kinase Domain 1 (apo)	0.107	187	132	26	174	4	190	3.140E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	0.106	284	249	27	310	6	285	1.265E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly1.cif.gz_A RSK2 N-terminal kinase domain in complex with ORF45	0.106	299	208	27	325	24	257	2.168E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.106	290	257	26	315	7	294	4.834E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8	LOKIASV2_1503_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	0.122	285	242	27	311	6	282	1.200E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	4eon-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4eon-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with the inhibitor RO3306	0.136	229	155	28	256	10	189	1.941E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	2wzj-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2wzj-assembly3.cif.gz_B Catalytic and UBA domain of kinase MARK2/(Par-1) K82R, T208E double mutant	0.105	301	211	26	326	4	240	2.685E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	0.118	289	185	26	314	6	216	1.414E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP	0.102	289	237	27	315	10	274	7.414E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	8fp1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8fp1-assembly1.cif.gz_A PKCeta kinase domain in complex with compound 2	0.134	292	229	27	318	10	275	1.265E-02	67
LOKIASV2_1503_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	0.101	286	230	26	311	8	264	6.663E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.092	300	247	26	325	13	285	1.026E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7jhh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7jhh-assembly1.cif.gz_A Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody	0.120	280	181	27	306	8	214	8.704E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	6c9d-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6c9d-assembly1.cif.gz_A Crystal structure of KA1-autoinhibited MARK1 kinase	0.106	285	225	26	310	7	259	5.675E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfe-assembly2.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4cfe-assembly2.cif.gz_A Structure of full length human AMPK in complex with a small molecule activator, a benzimidazole derivative (991)	0.106	285	224	27	311	11	262	8.704E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.111	294	232	27	320	10	271	7.028E-03	67
LOKIASV2_1503_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.131	206	127	28	233	9	155	1.078E-02	66
LOKIASV2_1503_ESMFold_hypothetical_protein	6mzq-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6mzq-assembly2.cif.gz_B TAS-120 in reversible binding mode with FGFR1	0.121	306	215	19	324	14	259	1.200E-02	66
LOKIASV2_1503_ESMFold_hypothetical_protein	7xmk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7xmk-assembly1.cif.gz_A Crystal structure of human RIPK1 kinase domain in complex with compound SKLB923	0.113	298	208	29	326	8	243	7.822E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly2.cif.gz_C BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	0.114	289	219	27	315	13	260	1.840E-02	66
LOKIASV2_1503_ESMFold_hypothetical_protein	7b36-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7b36-assembly2.cif.gz_C MST4 in complex with compound G-5555	0.138	298	220	27	324	11	266	1.491E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_A Crystal structure of JAK2 JH2-K539L	0.142	300	221	26	325	8	265	8.704E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	7vdp-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7vdp-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	0.112	285	245	26	310	1	277	9.182E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	5lqf-assembly2.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5lqf-assembly2.cif.gz_D CDK1/CyclinB1/CKS2 in complex with NU6102	0.108	283	243	28	310	11	283	8.251E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.098	298	240	27	324	18	284	2.403E-02	66
LOKIASV2_1503_ESMFold_hypothetical_protein	6qfl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qfl-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 active conformation	0.123	301	229	26	326	18	279	1.948E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	5oy6-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5oy6-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36.	0.112	275	183	27	301	8	214	7.028E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	0.108	288	235	28	315	12	275	2.545E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	8fh4-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8fh4-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-[6-chloro-4-(9-methyl-1-oxa-4,9-diazaspiro[5.5]undec-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile	0.121	301	215	26	326	13	258	1.200E-02	66
LOKIASV2_1503_ESMFold_hypothetical_protein	4l46-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4l46-assembly1.cif.gz_A Crystal structures of human p70S6K1-WT	0.142	292	226	27	318	15	278	1.200E-02	66
LOKIASV2_1503_ESMFold_hypothetical_protein	4ra4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4ra4-assembly1.cif.gz_A Crystal Structure of Human Protein Kinase C Alpha in Complex with Compound 28 ((R)-6-((3S,4S)-1,3-Dimethyl-piperidin-4-yl)-7-(2-fluoro-phenyl)-4-methyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)	0.133	289	230	27	315	11	276	1.078E-02	66
LOKIASV2_1503_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_B Kinase and Ubiquitin-associated domains of MARK3/Par-1	0.112	295	190	26	320	13	227	3.701E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	4yom-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4yom-assembly1.cif.gz_B Structure of SAD kinase	0.127	283	217	27	309	10	259	5.380E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	6i5i-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6i5i-assembly1.cif.gz_A Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound 12h	0.134	312	246	28	312	20	331	1.660E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27	0.108	301	227	18	318	104	359	1.847E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.090	290	248	26	315	161	434	8.704E-03	66
LOKIASV2_1503_ESMFold_hypothetical_protein	8sam-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.135	311	221	15	325	209	465	5.697E-04	66
LOKIASV2_1503_ESMFold_hypothetical_protein	6c1b-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6c1b-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37118	0.123	306	211	19	324	13	254	9.686E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzq-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzq-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_29 AKA 6-[(5-FLUORO-4-METH YLPYRIDIN-2-YL)AMINO]-4-({2-METHOXY-3-[(PYRIDIN-2-YLMETHYL )CARBAMOYL]PHENYL}AMINO)-N-METHYLPYRIDINE-3-CARBOXAMIDE	0.127	289	180	27	315	13	219	9.686E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8s99-assembly2.cif.gz_B Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	0.115	291	218	27	317	14	260	1.486E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	6ib2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6ib2-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 4a	0.110	299	212	26	324	18	256	2.287E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	3com-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3com-assembly1.cif.gz_A Crystal structure of Mst1 kinase	0.094	300	239	27	326	2	266	2.675E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.124	287	212	28	314	9	251	1.022E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	3aqv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3aqv-assembly1.cif.gz_A Human AMP-activated protein kinase alpha 2 subunit kinase domain (T172D) complexed with compound C	0.110	296	224	27	322	12	264	7.028E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4usd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4usd-assembly1.cif.gz_A Human STK10 (LOK) with SB-633825	0.115	301	225	26	326	14	268	2.413E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	5kbq-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5kbq-assembly2.cif.gz_B Pak1 in complex with bis-anilino pyrimidine inhibitor	0.137	318	205	9	326	3	241	9.182E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032	0.140	229	133	28	256	8	163	1.941E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	3ezv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ezv-assembly1.cif.gz_A CDK-2 with indazole inhibitor 9 bound at its active site	0.107	299	220	28	326	8	254	1.137E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	1agw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1agw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR	0.117	298	230	27	324	15	276	8.251E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	0.114	299	224	28	326	25	278	1.660E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	0.106	300	233	26	325	8	269	4.344E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4fzf-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4fzf-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with DKI	0.115	314	240	12	325	1	272	1.022E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	3g51-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3g51-assembly1.cif.gz_A Structural diversity of the active conformation of the N-terminal kinase domain of p90 ribosomal S6 kinase 2	0.125	292	214	27	318	25	270	1.948E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310	0.102	300	210	27	326	13	247	1.941E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	7uxi-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7uxi-assembly1.cif.gz_A Structure of CDK2 in complex with FP19711, a Helicon Polypeptide	0.109	291	173	26	316	5	199	9.182E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	3com-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3com-assembly2.cif.gz_B Crystal structure of Mst1 kinase	0.099	310	246	16	325	4	277	3.701E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	1xjd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1xjd-assembly1.cif.gz_A Crystal Structure of PKC-theta complexed with Staurosporine at 2A resolution	0.130	300	231	27	326	6	271	2.278E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_C-2	LOKIASV2_1503_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_C-2 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.114	291	231	27	317	15	276	1.941E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	0.122	301	212	26	326	12	254	5.100E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	5dh3-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5dh3-assembly1.cif.gz_B Crystal structure of MST2 in complex with XMU-MP-1	0.108	300	243	26	325	11	283	2.403E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.	0.109	298	235	27	324	20	284	1.200E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	3ns9-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ns9-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor BS-194	0.128	208	116	28	235	6	139	1.486E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	2i40-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2i40-assembly1.cif.gz_A Cdk2/Cyclin A complexed with a thiophene carboxamide inhibitor	0.122	297	217	28	324	8	255	5.987E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6zgc-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	0.118	276	184	26	301	5	214	8.704E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	8b54-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	8b54-assembly2.cif.gz_C CDK2/cyclin A2 in complex with pyrazolo[4,3-d]pyrimidine inhibitor LGR6768	0.123	299	232	28	326	8	273	1.335E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	6guc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6guc-assembly1.cif.gz_A CDK2/CyclinA in complex with SU9516	0.125	229	152	28	256	9	183	2.278E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	6w4p-assembly1.cif.gz_H	LOKIASV2_1503_ESMFold_hypothetical_protein	6w4p-assembly1.cif.gz_H CaMKII alpha-30 Cryo-EM reconstruction - Class B	0.108	300	252	26	325	8	290	1.486E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	1zmu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1zmu-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK2/PAR-1: Wild type	0.150	111	89	26	131	2	112	6.637E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor NU6102	0.121	289	180	28	316	9	214	2.160E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4eoo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4eoo-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with ATP	0.107	299	235	28	326	10	273	1.567E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4eos-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4eos-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor RO3306	0.116	299	233	28	326	11	275	1.022E-02	65
LOKIASV2_1503_ESMFold_hypothetical_protein	8aoh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8aoh-assembly1.cif.gz_A Specific covalent inhibitor(18) of ERK2	0.087	297	265	26	322	17	307	7.822E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.099	306	275	16	321	2	307	2.685E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c	0.125	302	222	17	318	102	356	2.168E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	4rer-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4rer-assembly1.cif.gz_A Crystal structure of the phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex bound to AMP and cyclodextrin	0.134	286	216	26	311	12	261	4.344E-03	65
LOKIASV2_1503_ESMFold_hypothetical_protein	7fcz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7fcz-assembly1.cif.gz_A Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor	0.110	298	198	29	326	8	230	3.325E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	6v2u-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6v2u-assembly2.cif.gz_B Crystal structure of the insect cell-expressed WT-BRAF kinase in complex with Dabrafenib	0.104	292	193	28	319	13	228	1.265E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	8sso-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8sso-assembly1.cif.gz_A AurA bound to danusertib and inhibiting monobody Mb2	0.098	288	221	26	313	8	253	1.567E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	3vqu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3vqu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridin-2- yl)amino]benzamide	0.108	299	204	28	326	14	243	4.118E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)	0.113	300	202	27	326	9	237	3.701E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4h58-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4h58-assembly2.cif.gz_B BRAF in complex with compound 3	0.106	297	220	28	324	14	260	2.822E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4usd-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4usd-assembly2.cif.gz_B Human STK10 (LOK) with SB-633825	0.106	301	226	26	326	14	267	1.751E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	7ydx-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ydx-assembly1.cif.gz_A Crystal structure of human RIPK1 kinase domain in complex with compound RI-962	0.117	289	230	29	317	10	270	1.840E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	6inl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6inl-assembly1.cif.gz_A Crystal structure of CDK2 IN complex with Inhibitor CVT-313	0.122	264	159	28	291	8	189	6.316E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	5kkr-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5kkr-assembly1.cif.gz_B KSR2:MEK1 Complex Bound to the Small Molecule APS-2-79	0.110	294	234	19	312	7	270	2.047E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4fzd-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4fzd-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with WSF motif	0.100	299	234	27	325	8	268	4.344E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B The Crystal Structure of MARK4 from Biortus.	0.105	292	195	27	318	8	226	5.987E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_A Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2	0.101	301	236	24	324	12	274	1.486E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4fza-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4fza-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex	0.124	265	228	27	287	8	272	1.847E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	6g78-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6g78-assembly2.cif.gz_B RSK4 N-terminal Kinase Domain S232E in complex with AMP-PNP	0.122	292	215	27	318	26	271	3.508E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4zsa-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4zsa-assembly2.cif.gz_B Crystal structure of FGFR1 kinase domain in complex with 7n	0.122	301	234	24	324	14	281	9.686E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A Cyclin Dependent Kinase 2 (CDK2) with diaminopyrimidine inhibitor	0.107	283	191	28	310	8	222	1.265E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	5b2l-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5b2l-assembly1.cif.gz_A A crucial role of Cys218 in the stabilization of an unprecedented auto-inhibition form of MAP2K7	0.108	299	233	26	324	16	277	3.152E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	6szm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6szm-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2009	0.118	291	244	27	317	10	287	2.833E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4eor-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4eor-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	0.115	299	233	28	326	9	272	2.403E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.107	299	222	28	326	17	266	1.137E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	3uc4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3uc4-assembly1.cif.gz_A The crystal structure of Snf1-related kinase 2.6	0.092	304	232	19	322	7	262	5.380E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	6yfz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yfz-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7), apo form	0.102	299	235	26	324	21	283	2.545E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4l43-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4l43-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389A (form I)	0.128	302	231	24	325	7	272	1.200E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	3e88-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3e88-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	0.104	292	236	27	318	10	273	2.047E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	6z2v-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6z2v-assembly1.cif.gz_A CLK3 A319V mutant bound with beta-carboline KH-CARB13 (Cpd 3)	0.098	306	255	28	311	27	332	4.118E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfe-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4cfe-assembly1.cif.gz_C Structure of full length human AMPK in complex with a small molecule activator, a benzimidazole derivative (991)	0.108	285	224	27	311	9	260	1.200E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	7myj-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7myj-assembly1.cif.gz_A Structure of full length human AMPK (a2b1g1) in complex with a small molecule activator MSG011	0.105	294	233	27	320	12	272	9.686E-03	64
LOKIASV2_1503_ESMFold_hypothetical_protein	8em8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8em8-assembly1.cif.gz_A Co-crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium falciparum in complex with RY-1-165	0.110	269	206	26	294	505	736	1.078E-02	64
LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly3.cif.gz_C CaMKIINtide Inhibitor Complex	0.108	283	220	28	310	5	252	9.182E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	8s9a-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8s9a-assembly2.cif.gz_B Crystal structure of the TYK2 pseudokinase domain in complex with TAK-279	0.119	300	210	27	326	15	253	5.675E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	8f7p-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8f7p-assembly1.cif.gz_B BRAF kinase in complex with LXH254 (naporafenib)	0.098	288	226	28	315	14	264	1.486E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	5uq3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5uq3-assembly1.cif.gz_A Crystal structure of human Cdk2-Spy1-P27 ternary complex	0.115	215	117	28	242	1	133	4.102E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	6hho-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6hho-assembly1.cif.gz_A Crystal structure of RIP1 kinase in complex with GSK547	0.118	292	232	26	317	9	272	1.653E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	5jq8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5jq8-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor ICEC0943	0.114	264	167	28	291	6	195	1.486E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	6jgm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6jgm-assembly1.cif.gz_A Crystal structure of CDK2 IN complex with Inhibitor NU-6140	0.111	291	173	26	316	3	198	5.100E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound WN316	0.110	289	231	28	316	6	266	4.834E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly5.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly5.cif.gz_E Crystal structure of human PAS kinase bound to ADP	0.105	294	234	17	310	5	266	2.278E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpb-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5lpb-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ADP from Arabidopsis thaliana	0.105	306	249	14	319	6	284	1.408E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	0.109	298	243	27	324	15	288	9.182E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 25)	0.132	299	235	28	326	18	289	4.118E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	6gro-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6gro-assembly1.cif.gz_A Human CSNK1G3 bound to SB-223133	0.126	293	236	25	317	5	275	3.904E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	4eop-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4eop-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	0.131	297	218	28	324	11	262	8.704E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	2izr-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2izr-assembly1.cif.gz_A Structure of casein kinase gamma 3 in complex with inhibitor	0.118	293	237	25	317	6	275	2.685E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	6u6a-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6u6a-assembly1.cif.gz_A Crystal structure of Yck2 from Candida albicans in complex with kinase inhibitor GW461484A	0.094	293	246	28	320	12	284	1.567E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	3qkl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3qkl-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.114	292	234	27	318	10	274	1.200E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	3txo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3txo-assembly1.cif.gz_A PKC eta kinase in complex with a naphthyridine	0.109	293	232	26	318	2	262	1.941E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	6qx9-assembly1.cif.gz_K	LOKIASV2_1503_ESMFold_hypothetical_protein	6qx9-assembly1.cif.gz_K Structure of a human fully-assembled precatalytic spliceosome (pre-B complex).	0.127	306	247	28	311	16	321	4.583E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	0.131	344	260	27	326	17	360	2.413E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	4ejn-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4ejn-assembly1.cif.gz_A Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide	0.112	300	222	27	326	109	359	3.904E-03	63
LOKIASV2_1503_ESMFold_hypothetical_protein	6b1u-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6b1u-assembly1.cif.gz_A Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	0.106	294	232	27	320	11	271	1.078E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	5dyk-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5dyk-assembly1.cif.gz_A Crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium falciparum - Apo form	0.109	293	238	28	320	528	795	1.335E-02	63
LOKIASV2_1503_ESMFold_hypothetical_protein	4c3r-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4c3r-assembly1.cif.gz_A Structure of dephosphorylated Aurora A (122-403) bound to AMPPCP	0.111	288	217	26	313	6	250	1.200E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	8tb5-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8tb5-assembly1.cif.gz_A TYK2 JH2 bound to Compound7	0.104	291	182	27	317	13	216	1.408E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	4mne-assembly2.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	4mne-assembly2.cif.gz_G Crystal structure of the BRAF:MEK1 complex	0.099	297	224	27	323	9	258	2.535E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	6c1o-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6c1o-assembly2.cif.gz_B FGFR1 kinase domain complexed with FIIN-1	0.111	306	220	19	324	12	259	3.889E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	3v5q-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3v5q-assembly1.cif.gz_A Discovery of a selective TRK Inhibitor with efficacy in rodent cancer tumor models	0.113	301	208	26	326	11	246	8.251E-03	62
LOKIASV2_1503_ESMFold_hypothetical_protein	5ur1-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5ur1-assembly2.cif.gz_B FGFR1 kinase domain complex with SN37333 in reversible binding mode	0.113	298	217	27	324	17	262	1.941E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(2,2,2-trifluoroacetyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide	0.110	289	220	27	315	15	262	1.408E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	6c4d-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6c4d-assembly1.cif.gz_A Structure based design of RIP1 kinase inhibitors	0.123	289	225	29	317	10	266	1.653E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	1oit-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1oit-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	0.111	285	187	26	310	1	211	8.251E-03	62
LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly7.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly7.cif.gz_A Crystal structure of SnRK2.6	0.079	311	237	12	322	2	259	1.265E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A Crystal structure of MAP2K7 complexed with a covalent inhibitor 12	0.122	303	225	22	324	15	271	3.325E-03	62
LOKIASV2_1503_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex an inhibitor G1858	0.124	301	209	26	326	13	252	1.265E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	6gu7-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6gu7-assembly1.cif.gz_A CDK1/Cks2 in complex with AZD5438	0.092	279	196	28	306	8	224	1.022E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	4use-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4use-assembly1.cif.gz_A Human STK10 (LOK) with SB-633825	0.107	300	240	26	325	14	283	2.988E-03	62
LOKIASV2_1503_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.117	301	216	26	326	12	257	1.265E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	6gue-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6gue-assembly2.cif.gz_C CDK2/CyclinA in complex with AZD5438	0.113	284	240	28	311	9	280	1.486E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2iw8-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.109	299	238	28	326	9	276	1.567E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	1fot-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1fot-assembly1.cif.gz_A STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE	0.136	285	220	26	310	5	260	2.822E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly4.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly4.cif.gz_G RSK2 N-terminal kinase domain in complex with ORF45	0.127	300	209	26	325	24	263	7.028E-03	62
LOKIASV2_1503_ESMFold_hypothetical_protein	6z4z-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6z4z-assembly2.cif.gz_B Crystal structure of CLK1 in complex with macrocycle ODS2004070	0.140	315	244	28	312	20	334	3.701E-03	62
LOKIASV2_1503_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1	0.112	312	222	15	326	86	336	3.325E-03	62
LOKIASV2_1503_ESMFold_hypothetical_protein	8gds-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	8gds-assembly3.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	0.098	308	261	10	317	47	336	2.047E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A Full-length human CaMKII	0.102	300	253	26	325	8	290	1.567E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	5wg3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5wg3-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258748	0.114	290	236	26	315	163	429	1.408E-02	62
LOKIASV2_1503_ESMFold_hypothetical_protein	8jpd-assembly1.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	8jpd-assembly1.cif.gz_G Focused refinement structure of GRK2 in NTSR1-GRK2-Galpha(q) complexes	0.096	299	263	28	326	194	485	7.414E-03	62
LOKIASV2_1503_ESMFold_hypothetical_protein	5tkd-assembly3.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	5tkd-assembly3.cif.gz_A-2 CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	0.108	300	202	27	326	12	239	2.977E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	7k7q-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7k7q-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-12 AKA:6-[(cyclopropanecarbonyl)amino]-4-({3-[6-(dimethylcarbamoyl)pyridazin-3-yl]-2-methoxyphenyl}amino)-N-methylpyridazine-3-carboxamide	0.098	301	208	26	326	9	240	7.822E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	0.099	301	209	26	326	6	238	1.335E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	3bht-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3bht-assembly2.cif.gz_C Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 3	0.126	284	221	28	311	9	262	1.078E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.118	298	206	28	325	12	245	1.653E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	3uc3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3uc3-assembly1.cif.gz_A The crystal structure of Snf1-related kinase 2.3	0.097	300	236	19	318	9	270	1.941E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ovm-assembly1.cif.gz_A Protein kinase MKK7 in complex with cyclobutyl-substituted indazole	0.118	299	224	26	324	18	272	7.414E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	3bhh-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3bhh-assembly3.cif.gz_C Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)	0.107	291	243	36	326	13	285	1.567E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	5o49-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5o49-assembly2.cif.gz_B Human FGF in complex with a covalent inhibitor	0.107	292	235	27	318	21	284	6.663E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.116	301	242	24	324	12	286	8.704E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	6yl1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yl1-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK37 at F80C	0.121	265	171	26	290	8	203	1.265E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	6lvm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6lvm-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	0.108	298	243	27	324	15	287	2.278E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	5ih8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5ih8-assembly1.cif.gz_A MELK in complex with NVS-MELK1	0.115	301	216	15	315	3	247	4.834E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	4ra5-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4ra5-assembly1.cif.gz_B Human Protein Kinase C THETA IN COMPLEX WITH LIGAND COMPOUND 11a (6-[(1,3-Dimethyl-azetidin-3-yl)-methyl-amino]-4(R)-methyl-7-phenyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)	0.129	308	235	19	326	3	273	2.822E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	6cnh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6cnh-assembly1.cif.gz_A Human PRPF4B in complex with Rebastinib	0.109	293	252	28	311	28	320	5.987E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	6r6e-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6r6e-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1-methyl-1H-indol-3-yl)pyrimidin-4-amine	0.135	311	244	28	310	13	323	7.822E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	5kq5-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5kq5-assembly1.cif.gz_A AMPK bound to allosteric activator	0.119	287	226	28	314	6	263	6.316E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	4qfg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4qfg-assembly1.cif.gz_A Structure of AMPK in complex with STAUROSPORINE inhibitor and in the absence of a synthetic activator	0.126	285	219	27	311	10	261	1.200E-02	61
LOKIASV2_1503_ESMFold_hypothetical_protein	7nh4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7nh4-assembly1.cif.gz_A Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3	0.118	301	222	18	318	104	356	2.545E-03	61
LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly2.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	5jt2-assembly2.cif.gz_D BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	0.095	290	196	28	317	16	233	3.889E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	6nyh-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nyh-assembly2.cif.gz_B Structure of human RIPK1 kinase domain in complex with GNE684	0.119	289	210	29	317	7	245	2.047E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	4fk3-assembly2.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4fk3-assembly2.cif.gz_A B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	0.101	290	215	26	315	9	248	2.977E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzp-assembly2.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzp-assembly2.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	0.125	289	180	27	315	13	219	9.182E-03	60
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzr-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzr-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	0.107	301	213	26	326	11	250	7.414E-03	60
LOKIASV2_1503_ESMFold_hypothetical_protein	7ax4-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7ax4-assembly2.cif.gz_B Human TYK2 pseudokinase domain (575-869) in complex with 5-(4-Fluoro-phenyl)-2-ureido-thiophene-3-carboxylic acid amide.	0.106	294	224	26	319	10	261	3.312E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	6fdy-assembly1.cif.gz_U	LOKIASV2_1503_ESMFold_hypothetical_protein	6fdy-assembly1.cif.gz_U Unc-51-Like Kinase 3 (ULK3) In Complex With Bosutinib	0.116	283	223	29	311	6	258	2.822E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5jsm-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	0.111	300	210	27	326	13	249	2.047E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_C Crystal structure of bRaf in complex with inhibitor GNE-0749	0.103	288	225	28	315	14	265	2.047E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.117	298	204	28	325	12	243	1.941E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	1dm2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1dm2-assembly1.cif.gz_A HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE	0.107	282	181	28	309	8	211	2.278E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A Dual specificity mitogen-activated protein kinase kinase 7 in complex with pyrazolopyrimidine 1a	0.109	299	222	26	324	18	267	6.663E-03	60
LOKIASV2_1503_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK24/SOS2	0.101	301	211	26	326	6	241	2.160E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1H-indol-3-yl)prop-2-yn-1-ol (AT17833) in an alternate binding site.	0.100	298	230	28	325	8	264	9.686E-03	60
LOKIASV2_1503_ESMFold_hypothetical_protein	5lpz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5lpz-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1196) in complex with ADP from Arabidopsis thaliana	0.123	299	242	15	313	8	284	1.137E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	2uv2-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	2uv2-assembly1.cif.gz_A-2 Crystal Structure Of Human Ste20-Like Kinase Bound To 4-(4-(5- Cyclopropyl-1H-pyrazol-3-ylamino)-quinazolin-2-ylamino)-phenyl)- acetonitrile	0.130	299	210	28	326	18	259	5.987E-03	60
LOKIASV2_1503_ESMFold_hypothetical_protein	2c47-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	2c47-assembly4.cif.gz_D Structure of casein kinase 1 gamma 2	0.135	297	233	25	321	3	272	8.251E-03	60
LOKIASV2_1503_ESMFold_hypothetical_protein	6g77-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6g77-assembly2.cif.gz_B RSK4 N-terminal Kinase Domain in complex with AMP-PNP	0.121	292	224	27	318	26	281	3.904E-03	60
LOKIASV2_1503_ESMFold_hypothetical_protein	1zmv-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1zmv-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK2/PAR-1: K82R mutant	0.098	288	204	26	313	2	228	1.941E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	6unp-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6unp-assembly1.cif.gz_A Crystal structure of the kinase domain of BMPR2-D485G	0.114	299	259	19	317	2	294	1.022E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.114	300	198	27	326	9	232	1.078E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB	0.107	289	236	27	315	10	274	2.278E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	0.115	292	233	27	318	10	273	4.102E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	0.127	319	246	28	310	22	340	1.022E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	4pl5-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4pl5-assembly2.cif.gz_C Crystal structure of murine IRE1 in complex with OICR573 inhibitor	0.112	282	213	29	310	15	255	1.840E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.120	293	223	28	320	25	278	1.078E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	8uaq-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8uaq-assembly1.cif.gz_A Crystal Structure of Human G Protein-Coupled Receptor Kinase 5 in Complex with GRL018-21	0.109	298	238	28	325	166	433	2.278E-02	60
LOKIASV2_1503_ESMFold_hypothetical_protein	5flf-assembly5.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	5flf-assembly5.cif.gz_E DISEASE LINKED MUTATION IN FGFR	0.109	290	218	24	313	10	255	1.941E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	6nzr-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nzr-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	0.106	301	214	26	326	9	248	8.251E-03	59
LOKIASV2_1503_ESMFold_hypothetical_protein	4xv9-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	4xv9-assembly1.cif.gz_A-2 B-Raf Kinase domain in complex with PLX5568	0.100	298	224	27	324	10	259	4.327E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	6nvl-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6nvl-assembly2.cif.gz_B FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	0.113	298	216	27	324	18	262	3.494E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	2wmb-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	2wmb-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	0.115	284	220	28	311	9	258	1.744E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_D Crystal structure of bRaf in complex with inhibitor GNE-0749	0.100	288	230	28	315	13	269	2.675E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	7jv0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7jv0-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor PD0325901	0.097	292	233	26	317	14	272	1.078E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_A Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	0.103	286	228	26	311	11	265	1.137E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_A Crystal structure of human PAS kinase bound to ADP	0.108	282	231	28	309	22	281	1.840E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	6cqe-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6cqe-assembly1.cif.gz_B Crystal structure of HPK1 kinase domain S171A mutant	0.112	300	216	27	326	13	256	2.278E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	7r9p-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7r9p-assembly1.cif.gz_A Crystal structure of HPK1 in complex with compound 14	0.112	300	216	27	326	13	256	1.744E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly3.cif.gz_C CDK11 in complex with small molecule inhibitor OTS964	0.100	286	251	26	311	2	281	2.278E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	6eim-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6eim-assembly1.cif.gz_B Human STK10 bound to GW683134A	0.126	298	239	28	325	18	291	7.028E-03	59
LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly1.cif.gz_A CDK11 in complex with small molecule inhibitor OTS964	0.112	284	244	28	311	7	282	2.160E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	6b3e-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6b3e-assembly2.cif.gz_C Crystal structure of human CDK12/CyclinK in complex with an inhibitor	0.088	284	255	28	311	13	293	1.408E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	4bkz-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4bkz-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with a benzodipyrazole inhibitor	0.137	297	204	15	311	3	239	5.987E-03	59
LOKIASV2_1503_ESMFold_hypothetical_protein	2gcd-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2gcd-assembly1.cif.gz_A TAO2 kinase domain-staurosporine structure	0.100	300	254	26	325	19	301	1.078E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	8aod-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8aod-assembly1.cif.gz_A Specific covalent inhibitor(14) of ERK2	0.089	297	264	26	322	17	307	1.840E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	0.113	284	232	28	311	12	273	1.078E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	3lj0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3lj0-assembly1.cif.gz_A IRE1 complexed with ADP and Quercetin	0.131	299	215	28	326	14	261	2.160E-02	59
LOKIASV2_1503_ESMFold_hypothetical_protein	7fd0-assembly1.cif.gz_B-2	LOKIASV2_1503_ESMFold_hypothetical_protein	7fd0-assembly1.cif.gz_B-2 Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor	0.113	298	205	29	326	8	239	2.047E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly2.cif.gz_B A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.096	274	166	45	318	66	250	2.047E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	5c03-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5c03-assembly1.cif.gz_A Crystal Structure of kinase	0.123	300	205	27	326	14	248	1.200E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly1.cif.gz_A STE20-like serine/threonine-protein kinase (SLK) in complex with Tivozanib	0.139	290	212	28	317	22	268	5.380E-03	58
LOKIASV2_1503_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_A Crystal structure of the V658F apo Jak1 pseudokinase domain	0.091	293	230	27	319	21	274	1.744E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_C FGFR2 in complex with YJ001	0.106	290	224	28	317	19	269	5.359E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 38	0.119	300	211	27	326	10	249	9.686E-03	58
LOKIASV2_1503_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.128	270	234	26	294	14	283	9.686E-03	58
LOKIASV2_1503_ESMFold_hypothetical_protein	6guh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6guh-assembly1.cif.gz_A CDK2 in complex with AZD5438	0.110	293	196	18	310	2	222	2.047E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly2.cif.gz_B Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.081	299	244	27	325	10	276	3.686E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	7vdp-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7vdp-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	0.111	282	248	29	310	3	282	1.567E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	2c47-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2c47-assembly1.cif.gz_A Structure of casein kinase 1 gamma 2	0.114	297	238	25	321	1	270	7.822E-03	58
LOKIASV2_1503_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.110	299	221	28	326	17	265	1.744E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	4eoi-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4eoi-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 K89D, Q131E - human cyclin A3 complex with the inhibitor RO3306	0.125	299	230	28	326	9	272	3.494E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	0.117	283	201	28	310	11	239	3.889E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	4q9z-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4q9z-assembly1.cif.gz_B Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)	0.123	301	233	26	326	8	274	3.494E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	3iec-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	3iec-assembly4.cif.gz_D Helicobacter pylori CagA Inhibits PAR1/MARK Family Kinases by Mimicking Host Substrates	0.103	287	224	26	312	4	254	1.744E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	5yks-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5yks-assembly1.cif.gz_A Crystal structure of sucrose nonfermenting-related kinase (SNRK)	0.108	312	274	14	325	1	308	3.889E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	3e87-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3e87-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	0.117	300	236	27	326	10	277	3.889E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	3tei-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3tei-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.115	296	250	26	321	18	301	1.744E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	6fyk-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6fyk-assembly2.cif.gz_B X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A	0.117	313	249	28	310	31	343	4.834E-03	58
LOKIASV2_1503_ESMFold_hypothetical_protein	4zhx-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4zhx-assembly1.cif.gz_A Novel binding site for allosteric activation of AMPK	0.104	290	258	27	315	10	299	1.941E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	4cff-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4cff-assembly1.cif.gz_C Structure of full length human AMPK in complex with a small molecule activator, a thienopyridone derivative (A-769662)	0.112	285	223	27	311	9	260	2.278E-02	58
LOKIASV2_1503_ESMFold_hypothetical_protein	6nze-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6nze-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	0.105	300	208	27	326	12	244	1.941E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	5ct7-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5ct7-assembly2.cif.gz_B BRAF in Complex with RAF265	0.096	297	217	28	324	13	253	5.653E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly4.cif.gz_D A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.096	274	170	45	318	58	246	2.822E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	5nwz-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5nwz-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	0.103	306	228	19	324	11	265	7.386E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	5vam-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5vam-assembly1.cif.gz_A BRAF in Complex with RAF709	0.097	297	230	28	324	13	268	3.140E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	1gij-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1gij-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR	0.113	299	215	28	326	8	250	1.744E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	1g5s-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1g5s-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717	0.126	297	201	28	324	8	238	2.535E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly2.cif.gz_B HPK1 IN COMPLEX WITH COMPOUND 38	0.113	300	208	27	326	10	244	1.022E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly2.cif.gz_B STE20-like serine/threonine-protein kinase (SLK) in complex with Tivozanib	0.139	297	219	28	324	22	276	5.987E-03	57
LOKIASV2_1503_ESMFold_hypothetical_protein	7ovl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7ovl-assembly1.cif.gz_A Protein kinase MKK7 in complex with methoxycyclohexyl-substituted indazole	0.114	299	222	26	324	18	269	1.200E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3dls-assembly7.cif.gz_C Crystal structure of human PAS kinase bound to ADP	0.122	282	223	28	309	22	276	1.840E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	8a66-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8a66-assembly2.cif.gz_B Crystal structure of MST2 in complex with XMU-MP-1	0.087	300	244	26	325	11	278	1.653E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	4eoj-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4eoj-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with ATP	0.106	299	224	28	326	12	262	3.686E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	3sqq-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3sqq-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-3-96	0.119	289	175	28	316	8	207	4.102E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2iw6-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.125	284	242	28	311	9	285	4.102E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	5oxg-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	5oxg-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854	0.120	290	254	26	315	9	298	1.567E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	4qpm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4qpm-assembly1.cif.gz_A Structure of Bub1 kinase domain	0.126	298	232	28	325	53	319	4.583E-03	57
LOKIASV2_1503_ESMFold_hypothetical_protein	6yty-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yty-assembly1.cif.gz_A CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)	0.101	319	265	28	323	34	352	1.137E-02	57
LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3kl8-assembly1.cif.gz_A CaMKIINtide Inhibitor Complex	0.107	283	223	28	310	2	252	3.312E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	4yht-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4yht-assembly1.cif.gz_A bRaf complexed with an inhibitor	0.120	299	202	28	326	13	242	6.637E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	6mzw-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6mzw-assembly2.cif.gz_B TAS-120 covalent complex with FGFR1	0.109	294	211	24	317	13	250	4.816E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4mne-assembly1.cif.gz_C Crystal structure of the BRAF:MEK1 complex	0.090	299	231	25	323	5	259	7.001E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	6nvl-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6nvl-assembly3.cif.gz_C FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	0.133	298	217	27	324	14	264	1.200E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	0.112	298	221	27	324	9	258	3.140E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly5.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly5.cif.gz_E A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.096	274	171	45	318	71	260	2.535E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	1r78-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1r78-assembly1.cif.gz_A CDK2 complex with a 4-alkynyl oxindole inhibitor	0.109	263	161	28	290	8	189	2.977E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	7sj3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7sj3-assembly1.cif.gz_A Structure of CDK4-Cyclin D3 bound to abemaciclib	0.097	283	242	27	309	5	273	2.977E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	1ckp-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1ckp-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B	0.119	283	184	28	310	8	217	6.291E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_A Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	0.115	297	205	30	326	8	240	3.312E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	8atb-assembly1.cif.gz_AAA	LOKIASV2_1503_ESMFold_hypothetical_protein	8atb-assembly1.cif.gz_AAA Discovery of IRAK4 Inhibitor 16	0.115	292	227	28	319	23	280	9.686E-03	56
LOKIASV2_1503_ESMFold_hypothetical_protein	3fz1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3fz1-assembly1.cif.gz_A Crystal structure of a benzthiophene inhibitor bound to human Cyclin-dependent Kinase-2 (CDK-2)	0.110	284	236	28	311	8	273	1.941E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	1buh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	1buh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1	0.108	294	245	26	319	6	281	1.137E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	1f5q-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	1f5q-assembly2.cif.gz_C CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2	0.106	209	131	28	236	3	150	7.386E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	5f9e-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5f9e-assembly2.cif.gz_B Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	0.122	299	231	28	326	10	273	5.359E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_E Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.089	285	233	27	311	10	266	2.047E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	0.140	284	195	28	311	15	242	5.080E-02	56
LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly5.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly5.cif.gz_E Crystal structure of SnRK2.6	0.091	187	163	27	206	9	195	2.822E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	4yht-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4yht-assembly2.cif.gz_B bRaf complexed with an inhibitor	0.113	298	199	28	325	13	237	9.147E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_A Crystal structure of bRaf in complex with inhibitor GNE-0749	0.123	297	217	28	324	13	260	3.312E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	5fd2-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5fd2-assembly1.cif.gz_A B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor	0.114	299	208	28	326	14	249	4.327E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	0.106	301	200	26	326	10	234	2.535E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	5wax-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5wax-assembly2.cif.gz_B Crystal Structure of Sugarcane SAPK10 (serine/threonine-protein kinase 10)	0.091	284	216	27	310	10	248	7.028E-03	55
LOKIASV2_1503_ESMFold_hypothetical_protein	6iuo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6iuo-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with a covalent inhibitor	0.119	301	223	24	324	21	274	3.889E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	5oo1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5oo1-assembly1.cif.gz_A Cdk2(F80C, C177A) covalent adduct with C37 at F80C	0.101	284	236	28	311	5	267	1.567E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	7xdy-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7xdy-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	0.108	292	233	28	319	19	280	1.653E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg7-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg7-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor SB1-G-23	0.105	299	226	26	324	17	269	2.160E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	0.114	301	217	26	326	8	253	3.312E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	5uq1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5uq1-assembly1.cif.gz_A Crystal structure of human Cdk2-Spy1 complex	0.107	294	245	28	321	6	280	4.565E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly5.cif.gz_I	LOKIASV2_1503_ESMFold_hypothetical_protein	7opo-assembly5.cif.gz_I RSK2 N-terminal kinase domain in complex with ORF45	0.122	301	228	26	326	24	284	6.663E-03	55
LOKIASV2_1503_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.113	285	207	27	311	9	242	8.251E-03	55
LOKIASV2_1503_ESMFold_hypothetical_protein	4imy-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4imy-assembly1.cif.gz_A The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat	0.108	293	260	19	311	9	301	2.403E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	5f9e-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5f9e-assembly1.cif.gz_A Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	0.139	301	229	26	326	8	274	4.816E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	7t4l-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7t4l-assembly1.cif.gz_A Structure of dimeric phosphorylated Pediculus humanus (Ph) PINK1 with extended alpha-C helix in chain B	0.096	292	252	26	317	33	312	2.160E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	4rew-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4rew-assembly1.cif.gz_A Crystal structure of the non-phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex	0.123	261	203	27	287	10	241	9.182E-03	55
LOKIASV2_1503_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	0.111	290	239	26	315	162	431	4.816E-02	55
LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly2.cif.gz_C The co-crystal structure of BRAF(V600E) with PHI1	0.107	288	216	28	315	13	255	4.327E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly3.cif.gz_C A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.097	274	169	45	318	66	253	3.312E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly1.cif.gz_G	LOKIASV2_1503_ESMFold_hypothetical_protein	8bem-assembly1.cif.gz_G STE20-like serine/threonine-protein kinase (SLK) in complex with Tivozanib	0.145	288	210	28	315	22	268	1.022E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	3uc4-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3uc4-assembly2.cif.gz_B The crystal structure of Snf1-related kinase 2.6	0.099	301	210	26	326	8	241	4.102E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	7vdq-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7vdq-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7	0.123	282	239	29	310	2	275	3.686E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	4tyj-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4tyj-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	0.113	298	220	27	324	26	274	8.219E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3udb-assembly2.cif.gz_B Crystal structure of SnRK2.6	0.075	296	231	27	322	10	260	2.822E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg7-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg7-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor SB1-G-23	0.108	299	222	26	324	18	267	1.486E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	2qkw-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2qkw-assembly1.cif.gz_B Structural basis for activation of plant immunity by bacterial effector protein AvrPto	0.126	290	239	26	315	13	286	1.941E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly2.cif.gz_B CDK11 in complex with small molecule inhibitor OTS964	0.105	285	248	27	311	6	283	5.964E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B Catalytic and ubiqutin-associated domains of MARK2/PAR-1: T208A/S212A inactive double mutant	0.092	294	223	26	319	5	251	1.744E-02	54
LOKIASV2_1503_ESMFold_hypothetical_protein	4r5y-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4r5y-assembly1.cif.gz_A The complex structure of Braf V600E kinase domain with a novel Braf inhibitor	0.119	299	198	28	326	13	238	2.977E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	3ckw-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ckw-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24)	0.100	261	219	27	287	5	248	2.535E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	4itj-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4itj-assembly1.cif.gz_A Crystal structure of RIP1 kinase in complex with necrostatin-4	0.103	298	209	29	326	10	243	3.889E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly1.cif.gz_A A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.097	274	170	45	318	65	253	2.403E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_B Crystal structure of bRaf in complex with inhibitor GNE-0749	0.095	291	233	25	315	5	262	8.219E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	6c4d-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6c4d-assembly2.cif.gz_B Structure based design of RIP1 kinase inhibitors	0.101	298	213	29	326	11	248	3.140E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	7fd0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7fd0-assembly1.cif.gz_A Crystal Structure of human RIPK1 kinase domain in complex with a novel inhibitor	0.110	301	211	26	326	11	248	4.565E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	5wax-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5wax-assembly1.cif.gz_A Crystal Structure of Sugarcane SAPK10 (serine/threonine-protein kinase 10)	0.086	300	210	27	326	11	241	3.312E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.113	301	204	26	326	12	242	2.403E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	4bc6-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	4bc6-assembly1.cif.gz_A-2 Crystal structure of human serine threonine kinase-10 bound to novel Bosutinib Isoform 1, previously thought to be Bosutinib	0.114	298	235	28	325	17	282	7.028E-03	53
LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly1.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.091	299	240	27	325	10	274	5.080E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	3tnw-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	3tnw-assembly2.cif.gz_C Structure of CDK2/cyclin A in complex with CAN508	0.121	297	221	28	324	8	259	3.889E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	4red-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4red-assembly1.cif.gz_A Crystal structure of human AMPK alpha1 KD-AID with K43A mutation	0.110	300	201	27	326	9	235	1.408E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfh-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4cfh-assembly1.cif.gz_A Structure of an active form of mammalian AMPK	0.110	285	225	27	311	7	260	1.486E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine	0.101	301	246	26	326	163	437	4.327E-02	53
LOKIASV2_1503_ESMFold_hypothetical_protein	4xv2-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4xv2-assembly1.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with Dabrafenib	0.083	286	214	28	313	14	247	6.291E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	5ita-assembly3.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5ita-assembly3.cif.gz_B Crystal Structure of BRAF Kinase Domain Bound to AZ-VEM	0.090	287	217	27	313	10	249	7.001E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly1.cif.gz_A The co-crystal structure of BRAF(V600E) with PHI1	0.110	286	214	28	313	13	254	6.291E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	4nzw-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4nzw-assembly1.cif.gz_B Crystal Structure of STK25-MO25 Complex	0.119	300	194	27	326	13	233	4.565E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	4bcp-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4bcp-assembly2.cif.gz_C Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor	0.123	287	214	28	314	9	253	2.977E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	7z6u-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7z6u-assembly1.cif.gz_A Pim1 in complex with (E)-4-((6-amino-2-oxoindolin-3-ylidene)methyl)benzoic acid and Pimtide	0.116	294	231	26	319	7	268	8.219E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	7juw-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7juw-assembly1.cif.gz_B Crystal Structure of KSR1:MEK1 in complex with AMP-PNP	0.123	301	219	26	326	14	264	2.822E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	4usf-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4usf-assembly1.cif.gz_A Human SLK with SB-440719	0.137	289	211	29	317	29	274	5.675E-03	52
LOKIASV2_1503_ESMFold_hypothetical_protein	3gni-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3gni-assembly1.cif.gz_B Structure of STRAD and MO25	0.097	294	242	27	320	24	292	1.335E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	7t3x-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7t3x-assembly1.cif.gz_A Structure of unphosphorylated Pediculus humanus (Ph) PINK1 D334A mutant	0.098	371	271	19	319	29	399	4.583E-03	52
LOKIASV2_1503_ESMFold_hypothetical_protein	6u7c-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6u7c-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258747	0.092	290	246	26	315	163	434	5.359E-02	52
LOKIASV2_1503_ESMFold_hypothetical_protein	3a61-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3a61-assembly1.cif.gz_A Crystal structure of unphosphorylated p70S6K1 (Form II)	0.123	286	201	27	312	8	237	9.649E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	4cfv-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4cfv-assembly1.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	0.103	284	222	28	311	9	256	3.494E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	2dyl-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2dyl-assembly1.cif.gz_A Crystal structure of human mitogen-activated protein kinase kinase 7 activated mutant (S287D, T291D)	0.111	299	218	26	324	17	262	3.140E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6p7g-assembly1.cif.gz_B The co-crystal structure of BRAF(V600E) with PHI1	0.098	288	234	28	315	13	272	8.670E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	3zuu-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3zuu-assembly1.cif.gz_A The structure of OST1 (D160A, S175D) kinase in complex with gold	0.101	300	208	27	326	12	243	4.327E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A HPK1 IN COMPLEX WITH COMPOUND 11	0.116	264	163	26	289	12	196	7.386E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	7b5r-assembly1.cif.gz_L	LOKIASV2_1503_ESMFold_hypothetical_protein	7b5r-assembly1.cif.gz_L Ubiquitin ligation to F-box protein substrates by SCF-RBR E3-E3 super-assembly: CUL1-RBX1-SKP1-SKP2-CKSHS1-Cyclin A-CDK2-p27	0.104	285	239	27	311	6	273	2.977E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly3.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly3.cif.gz_C Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.089	300	240	26	325	11	274	2.278E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg1-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg1-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) in an active state, allosterically triggered by the N-terminal helix	0.129	299	233	26	324	27	295	2.160E-02	51
LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly5.cif.gz_E	LOKIASV2_1503_ESMFold_hypothetical_protein	4lg4-assembly5.cif.gz_E Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.081	299	236	27	325	10	267	5.359E-02	50
LOKIASV2_1503_ESMFold_hypothetical_protein	4usf-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	4usf-assembly2.cif.gz_B Human SLK with SB-440719	0.125	289	221	29	317	29	282	8.704E-03	50
LOKIASV2_1503_ESMFold_hypothetical_protein	6ng0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6ng0-assembly1.cif.gz_A Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with sunitinib in the inactive state.	0.116	300	210	27	326	12	250	6.637E-02	50
LOKIASV2_1503_ESMFold_hypothetical_protein	2cci-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	2cci-assembly2.cif.gz_C Crystal structure of phospho-CDK2 Cyclin A in complex with a peptide containing both the substrate and recruitment sites of CDC6	0.099	284	251	28	311	9	288	7.791E-02	50
LOKIASV2_1503_ESMFold_hypothetical_protein	4bbm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4bbm-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312	0.100	299	267	27	325	12	309	3.312E-02	50
LOKIASV2_1503_ESMFold_hypothetical_protein	2jed-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2jed-assembly2.cif.gz_B The crystal structure of the kinase domain of the protein kinase C theta in complex with NVP-XAA228 at 2.32A resolution.	0.123	301	235	26	326	5	273	7.386E-02	50
LOKIASV2_1503_ESMFold_hypothetical_protein	1kob-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	1kob-assembly1.cif.gz_B TWITCHIN KINASE FRAGMENT (APLYSIA), AUTOREGULATED PROTEIN KINASE DOMAIN	0.120	300	212	27	326	34	275	3.686E-02	50
LOKIASV2_1503_ESMFold_hypothetical_protein	4cff-assembly2.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4cff-assembly2.cif.gz_A Structure of full length human AMPK in complex with a small molecule activator, a thienopyridone derivative (A-769662)	0.122	285	220	27	311	11	262	3.312E-02	50
LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly6.cif.gz_F	LOKIASV2_1503_ESMFold_hypothetical_protein	6m7z-assembly6.cif.gz_F A divergent kinase lacking the glycine-rich loop regulates membrane ultrastructure of the Toxoplasma parasitophorous vacuole	0.111	274	164	45	318	66	250	3.140E-02	49
LOKIASV2_1503_ESMFold_hypothetical_protein	4rc3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4rc3-assembly1.cif.gz_A Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivatives	0.118	292	233	26	317	7	271	1.330E-01	49
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg6-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg6-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor TL10-105	0.103	299	228	26	324	16	270	6.637E-02	49
LOKIASV2_1503_ESMFold_hypothetical_protein	6eim-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6eim-assembly1.cif.gz_A Human STK10 bound to GW683134A	0.103	300	216	27	326	11	252	2.675E-02	49
LOKIASV2_1503_ESMFold_hypothetical_protein	6cqe-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6cqe-assembly1.cif.gz_A Crystal structure of HPK1 kinase domain S171A mutant	0.116	300	214	27	326	14	256	4.565E-02	49
LOKIASV2_1503_ESMFold_hypothetical_protein	6gub-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6gub-assembly2.cif.gz_C CDK2/CyclinA in complex with Flavopiridol	0.118	289	238	28	316	9	279	5.359E-02	49
LOKIASV2_1503_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	0.088	292	244	26	317	4	272	1.941E-02	49
LOKIASV2_1503_ESMFold_hypothetical_protein	6rln-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6rln-assembly1.cif.gz_A Crystal structure of RIP1 kinase in complex with GSK3145095	0.114	299	212	28	326	9	248	4.327E-02	48
LOKIASV2_1503_ESMFold_hypothetical_protein	7lvh-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	7lvh-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	0.100	299	214	28	326	16	254	1.195E-01	48
LOKIASV2_1503_ESMFold_hypothetical_protein	6yg6-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6yg6-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor TL10-105	0.107	299	229	26	324	17	273	7.386E-02	48
LOKIASV2_1503_ESMFold_hypothetical_protein	2wip-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2wip-assembly1.cif.gz_A STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO- 1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID	0.111	308	242	19	326	2	274	1.480E-01	48
LOKIASV2_1503_ESMFold_hypothetical_protein	3my1-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3my1-assembly1.cif.gz_A Structure of CDK9/cyclinT1 in complex with DRB	0.117	291	251	27	311	14	304	5.080E-02	48
LOKIASV2_1503_ESMFold_hypothetical_protein	6z0f-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6z0f-assembly1.cif.gz_A Crystal structure of the membrane pseudokinase YukC/EssB from Bacillus subtilis T7SS	0.093	313	182	12	324	3	204	3.494E-02	48
LOKIASV2_1503_ESMFold_hypothetical_protein	8dgs-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8dgs-assembly1.cif.gz_A Cryo-EM structure of a RAS/RAF complex (state 1)	0.095	300	224	27	326	146	394	2.822E-02	48
LOKIASV2_1503_ESMFold_hypothetical_protein	4oli-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4oli-assembly1.cif.gz_A The pseudokinase/kinase protein from JAK-family member TYK2	0.122	301	211	26	326	10	250	2.535E-02	48
LOKIASV2_1503_ESMFold_hypothetical_protein	7qfm-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	7qfm-assembly1.cif.gz_A Pim1 in complex with (E)-4-((2-oxoindolin-3-ylidene)methyl)benzoic acid and Pimtide	0.119	294	233	26	319	7	271	1.833E-01	47
LOKIASV2_1503_ESMFold_hypothetical_protein	5n4x-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5n4x-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like molekule 4,5-dibromothiophene-2-carbohydrazide	0.116	286	222	26	311	7	258	1.561E-01	47
LOKIASV2_1503_ESMFold_hypothetical_protein	3ig7-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ig7-assembly1.cif.gz_A Novel CDK-5 inhibitors - crystal structure of inhibitor EFP with CDK-2	0.125	289	223	28	316	8	263	3.312E-02	47
LOKIASV2_1503_ESMFold_hypothetical_protein	7qhl-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	7qhl-assembly2.cif.gz_C Crystal structure of Cyclin-dependent kinase 2/cyclin A in complex with 3,5,7-Substituted pyrazolo[4,3-d]pyrimidine inhibitor 24	0.122	299	233	28	326	3	268	1.330E-01	47
LOKIASV2_1503_ESMFold_hypothetical_protein	1h27-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	1h27-assembly2.cif.gz_C CDK2/CyclinA in complex with an 11-residue recruitment peptide from p27	0.114	299	232	28	326	9	271	1.261E-01	47
LOKIASV2_1503_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_B Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.099	291	240	27	317	12	278	5.653E-02	47
LOKIASV2_1503_ESMFold_hypothetical_protein	5hnb-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5hnb-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH [6-Hydroxy-3-(3-methyl-benzyl)-1H-indazol-5-yl]-((S)-3-hydroxy-pyrrolidin-1-yl)-methanone	0.108	318	268	10	311	2	319	1.195E-01	47
LOKIASV2_1503_ESMFold_hypothetical_protein	6r5f-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	6r5f-assembly2.cif.gz_B Crystal structure of RIP1 kinase in complex with DHP77	0.103	291	203	36	326	12	238	1.737E-01	46
LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	7l26-assembly4.cif.gz_D HPK1 IN COMPLEX WITH COMPOUND 38	0.105	268	234	27	294	10	272	1.133E-01	46
LOKIASV2_1503_ESMFold_hypothetical_protein	4nj3-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4nj3-assembly1.cif.gz_A Modulating the interaction between CDK2 and Cyclin A with a Quinoline-based inhibitor	0.099	289	230	28	316	8	263	3.889E-02	46
LOKIASV2_1503_ESMFold_hypothetical_protein	2iw6-assembly2.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	2iw6-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.116	284	247	28	311	9	288	1.195E-01	46
LOKIASV2_1503_ESMFold_hypothetical_protein	4eom-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4eom-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with ATP	0.097	300	233	26	325	5	263	7.386E-02	46
LOKIASV2_1503_ESMFold_hypothetical_protein	3og7-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3og7-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX4032	0.106	291	207	28	318	13	245	3.300E-01	45
LOKIASV2_1503_ESMFold_hypothetical_protein	7r9l-assembly1.cif.gz_A-2	LOKIASV2_1503_ESMFold_hypothetical_protein	7r9l-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex with compound 2	0.097	300	217	27	326	11	251	1.561E-01	45
LOKIASV2_1503_ESMFold_hypothetical_protein	8bzo-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8bzo-assembly1.cif.gz_A Cryo-EM structure of CDK2-CyclinA in complex with p27 from the SCFSKP2 E3 ligase Complex	0.104	140	123	27	164	5	144	1.074E-01	45
LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_C Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.086	316	252	10	325	6	282	2.160E-02	45
LOKIASV2_1503_ESMFold_hypothetical_protein	4d28-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	4d28-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK24/SOS2	0.100	300	211	27	326	4	238	1.833E-01	44
LOKIASV2_1503_ESMFold_hypothetical_protein	2bcj-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	2bcj-assembly1.cif.gz_A Crystal Structure of G Protein-Coupled Receptor Kinase 2 in Complex with Galpha-q and Gbetagamma Subunits	0.104	291	239	28	318	168	435	2.270E-01	42
LOKIASV2_1503_ESMFold_hypothetical_protein	8afr-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8afr-assembly1.cif.gz_A Pim1 in complex with 4-((6-hydroxybenzofuran-3-yl)methyl)benzoic acid and Pimtide	0.133	276	205	36	311	14	250	4.086E-01	41
LOKIASV2_1503_ESMFold_hypothetical_protein	8bya-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	8bya-assembly1.cif.gz_A Cryo-EM structure of SKP1-SKP2-CKS1-CDK2-CyclinA-p27KIP1 Complex	0.111	212	115	27	238	3	132	5.060E-01	41
LOKIASV2_1503_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and [2-oxo-2-(1H-pyrrol-2-yl)ethyl] 5-bromo-1H-indole-3-carboxylate	0.110	294	236	26	319	7	272	4.311E-01	40
LOKIASV2_1503_ESMFold_hypothetical_protein	3ujg-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	3ujg-assembly1.cif.gz_A Crystal structure of SnRK2.6 in complex with HAB1	0.115	283	235	28	294	6	288	4.327E-02	40
LOKIASV2_1503_ESMFold_hypothetical_protein	3c4c-assembly2.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	3c4c-assembly2.cif.gz_B B-Raf Kinase in Complex with PLX4720	0.124	295	199	25	319	6	233	1.833E-01	39
LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly4.cif.gz_D	LOKIASV2_1503_ESMFold_hypothetical_protein	7ukz-assembly4.cif.gz_D CDK11 in complex with small molecule inhibitor OTS964	0.127	261	180	26	286	1	207	4.797E-01	39
LOKIASV2_1503_ESMFold_hypothetical_protein	6hv0-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6hv0-assembly1.cif.gz_A IRE1 kinase/RNase in complex with imidazo[1,2-b]pyridazin-8-amine compound 33	0.128	283	204	28	310	14	248	9.147E-02	39
LOKIASV2_1503_ESMFold_hypothetical_protein	6sg4-assembly1.cif.gz_C	LOKIASV2_1503_ESMFold_hypothetical_protein	6sg4-assembly1.cif.gz_C Structure of CDK2/cyclin A M246Q, S247EN	0.102	267	225	45	311	3	253	7.357E-01	36
LOKIASV2_1503_ESMFold_hypothetical_protein	6ath-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6ath-assembly1.cif.gz_A Cdk2/cyclin A/p27-KID-deltaC	0.118	270	227	42	311	10	267	5.941E-01	36
LOKIASV2_1503_ESMFold_hypothetical_protein	5yks-assembly1.cif.gz_B	LOKIASV2_1503_ESMFold_hypothetical_protein	5yks-assembly1.cif.gz_B Crystal structure of sucrose nonfermenting-related kinase (SNRK)	0.087	296	229	16	311	2	253	5.941E-01	35
LOKIASV2_1503_ESMFold_hypothetical_protein	6sg4-assembly1.cif.gz_A	LOKIASV2_1503_ESMFold_hypothetical_protein	6sg4-assembly1.cif.gz_A Structure of CDK2/cyclin A M246Q, S247EN	0.099	267	227	45	311	3	255	1.474E+00	23
